id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,notes,is_data_in_figure_graphics,is_relevant_data_in_table,is_table_in_graphic_format,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,tiktoken_without_attributes_markdown_token_num,split,output
458,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,20,,20,,,,All numerical values are in a graphical format of table.,FALSE,TRUE,TRUE,FALSE,1396,1236,1068,TEST,B) continuous
389,875,2974815,percentage of patients with controlled blood pressure,"phone calls"" group","no phone calls"" group",binary,86,108,175,246,,,,,"Used 80% for ""phone calls"" group and 71% for ""no phone calls"" group.",FALSE,FALSE,FALSE,TRUE,13659,6016,4469,TEST,B) continuous
32,5580,3003523,Pain,Certolizumab 400 mg,Control,continuous,,390,,199,53.9,22.2,34,20.1,Used values for weeks 52 (final timepoint).,FALSE,TRUE,FALSE,TRUE,12247,10091,7520,TEST,B) continuous
557,9830,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Casein shake (Placebo),continuous,,12,,16,-17.1,68.08,-19.57,93.53,From per protocol,FALSE,TRUE,FALSE,TRUE,6022,3786,2937,TEST,B) continuous
570,8558,5541727,Symptom improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,6118,5345,4032,TEST,B) continuous
681,13506,5777419,reduction of plaque,probiotic,placebo,continuous,,16,,15,28.1,14.6,27.4,13,found in table 2,FALSE,TRUE,FALSE,TRUE,9410,4699,3181,TEST,B) continuous
522,6698,5154016,Total drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,248.5,18.8,318.5,26.7,,FALSE,TRUE,FALSE,TRUE,3046,2156,1642,TEST,B) continuous
634,12289,5777645,HbA1c levels,to peer-led structured patient education,conventional care alone,continuous,,70,,70,1.05,2,0.15,1.7,SDs found in abstract while group sizes and means found in table 2,FALSE,TRUE,FALSE,TRUE,8661,5060,3738,TEST,B) continuous
346,10233,5686687,Need for dipyrone,Resveratrol,Placebo,continuous,,22,,22,1944,1793,625,250,found in table,FALSE,TRUE,FALSE,TRUE,7451,3515,2366,TEST,B) continuous
644,12880,5830087,progression-free survival,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,"given as median with confidence interval, cannot calculate",FALSE,TRUE,FALSE,FALSE,11942,10628,8141,TEST,B) continuous
539,7795,3508963,Baseline characteristics - did not have hydronephrosis,Intravenous lidocaine,Intravenous morphine,binary,11,120,15,120,,,,,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
271,2991,3214395,laryngoscopy failure,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 48",group 3 involved bispectral index (BIS) of 38,continuous,,60,,30,,,,,mean and std not given for group 1 and 2 combined,FALSE,TRUE,TRUE,FALSE,1201,996,880,TEST,B) continuous
85,13567,3687098,The incidence rates of malignancy,sitagliptin 100 mg/day,comparator agent,binary,6953,7726,6403,6885,,,,,Used incidence rate per 100 to get the binary events.,FALSE,FALSE,FALSE,TRUE,15196,10904,8432,TEST,B) continuous
413,3262,3475525,Taste perception,MTL+caloric intake group,No label group,continuous,,90,,99,5.4,1.4,5.8,1.4,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
542,7795,3508963,Baseline characteristics - right kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,57,120,,,,,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
202,5498,5380326,Interferon gamma-induced protein 10,Vitamin D supplementation,Control,continuous,,40,,40,636.47,448.47,748.88,551,,FALSE,TRUE,FALSE,TRUE,10658,5810,4260,TEST,B) continuous
21,3243,2972614,Severity of pain,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,3.76,1.45,4.63,2.1,,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
353,4496,5874317,Squat jump,Bilateral training,Unilateral training,continuous,,9,,9,0.37,0.04,0.34,0.04,Found in table raw values,FALSE,TRUE,FALSE,TRUE,10785,5696,4631,TEST,B) continuous
471,4803,5515881,spatial score,demanding balance training program,relaxation group,continuous,,,,,0.443,0.75,0.04,0.91,Group sizes are in methods section only. Numerical values are from posttest.,TRUE,TRUE,FALSE,FALSE,4475,3500,2868,TEST,B) continuous
571,8559,5541727,SF-36 bodily pain score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,6118,5345,4032,TEST,B) continuous
124,7937,4486927,The SVR rates when the patients had BMI >30 kg/m2,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,10,19,6,12,,,,,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",FALSE,TRUE,FALSE,TRUE,14472,7883,5770,TEST,B) continuous
585,10216,3504298,Depressive symptoms,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,"F-values given, cant use for point estimates",FALSE,FALSE,FALSE,FALSE,4963,4205,3331,TEST,B) continuous
621,11904,3493722,eradication rate of H. pylori in ITT,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,85,72,84,,,,,"found in abstract and table, assumed binary because given as percentage of population",FALSE,FALSE,FALSE,TRUE,1684,1549,1357,TEST,B) continuous
463,4431,5726464,Lipid profile: HDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
352,4495,5874317,Change of direction improvement,Bilateral training,Unilateral training,continuous,,9,,9,5.46,0.2,5.67,0.16,Found in table raw values,FALSE,TRUE,FALSE,TRUE,10785,5696,4631,TEST,B) continuous
610,11584,115849,Swollen joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
8,9683,2363753,Days with fever,Amifostine,Control,continuous,,20,,20,,,,,Only abstract is available. Full text in PDF only.,FALSE,FALSE,FALSE,FALSE,887,780,725,TEST,B) continuous
437,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,No label group,continuous,,90,,99,94.1,15.6,42.6,20.7,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
91,5539,3912320,"Correct response rate for 2,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,Mean were in a figure and SD was not given anywhere.,TRUE,FALSE,FALSE,FALSE,1648,1217,1015,TEST,B) continuous
351,4494,5874317,Knee flexion (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,99.8,10.2,86.8,2.9,Found in table raw values,FALSE,TRUE,FALSE,TRUE,10785,5696,4631,TEST,B) continuous
512,6553,4033571,Adverse effects,Extended-release oxcarbazepine 1200 mg,Control,binary,69,123,67,122,,,,,,FALSE,TRUE,FALSE,TRUE,8206,5593,4514,TEST,B) continuous
373,220,1475568,Baseline beta-blockers intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,32,59,46,64,,,,,Used percentage found in table to calculate actual number for binary variable.,FALSE,TRUE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
23,3247,2972614,Laboratory parameters,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,,,,,Unclear outcome and also no numerical data for this specific outcome,FALSE,FALSE,FALSE,FALSE,7041,2968,1931,TEST,B) continuous
136,2448,4574984,postoperative in-hospital stay,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",continuous,,326,,326,,,,,Only median and interquartile range is given.,FALSE,FALSE,FALSE,FALSE,12997,7944,5795,TEST,B) continuous
14,12634,2667135,early discontinuations,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,10,103,54,97,,,,,,FALSE,TRUE,FALSE,TRUE,11722,8106,5529,TEST,B) continuous
682,13506,5777419,attachment gain,antibiotic,placebo,continuous,,16,,15,4.1,1,4.3,1.4,found in table 2,FALSE,TRUE,FALSE,TRUE,9410,4699,3181,TEST,B) continuous
384,877,2974815,The percentage of patients with controlled blood pressure (<140/90 mmHg),"phone calls"" group","no phone calls"" group",binary,,108,,246,,,,,Numerical values are not available.,FALSE,FALSE,FALSE,FALSE,13659,6016,4469,TEST,B) continuous
511,6550,4033571,Overall seizure median percent improvement,Extended-release oxcarbazepine 2400 mg,Control,continuous,,111,,117,-42.9,,-28.7,,SD was not given,FALSE,FALSE,FALSE,FALSE,8206,5593,4514,TEST,B) continuous
249,10310,5571493,Hypoglycemia,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,No numerical values are given.,FALSE,FALSE,FALSE,FALSE,1507,1019,928,TEST,B) continuous
550,9719,3648394,LF:HF component of HRV,10-week yoga program,Control,continuous,,18,,19,0.35,0.43,0.04,0.38,Numerical values are from Week 11.,FALSE,TRUE,FALSE,TRUE,9556,6245,4261,TEST,B) continuous
347,10234,5686687,Need for Ibuprofen,Resveratrol,Placebo,continuous,,22,,22,1200,848,5640,328,found in table,FALSE,TRUE,FALSE,TRUE,7451,3515,2366,TEST,B) continuous
495,6488,5419060,Request-form errors: CHC A,Phlebotomy training programme,Control,binary,8,10218,11,7557,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
306,7831,4541185,duration of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,703.83,42.9,556.38,37.96,found in text,FALSE,TRUE,TRUE,TRUE,1359,1043,907,TEST,B) continuous
77,3746,3546023,The percentage of NK cells,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,19.03,7.82,24.72,8.78,Values are between baseline and week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
329,5376,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 96 mg,continuous,,5,,5,,,,,found in table,FALSE,TRUE,TRUE,FALSE,1146,884,721,TEST,B) continuous
535,7793,3508963,Response to treatment,Intravenous lidocaine,Intravenous morphine,binary,108,120,84,120,,,,,,FALSE,FALSE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
67,3041,3321528,wrist flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,Only median and interquartile range is given.,FALSE,TRUE,FALSE,FALSE,6725,3999,2880,TEST,B) continuous
632,12276,3936115,the number of abdominal ultrasound examinations performed for suspected diverticulitis and subsequent number of diverticulitis diagnosed based on abdominal US,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,1,30,5,22,,,,,found in table 2,FALSE,TRUE,FALSE,TRUE,2217,2016,1562,TEST,B) continuous
42,6985,3169777,unexpected adverse events,macitentan doses of 300 mg,placebo,binary,0,6,0,14,,,,,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,FALSE,FALSE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
594,11583,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
255,10572,5711682,In-stent late lumen loss at 9 months,Genoss drug-eluting stent (DES),Promus Element,continuous,,38,,39,0.11,0.25,0.16,0.43,,FALSE,TRUE,FALSE,TRUE,13148,4660,2966,TEST,B) continuous
86,13568,3687098,The incidence rates of pancreatitis,sitagliptin 100 mg/day,comparator agent,binary,773,7726,689,6885,,,,,Used incidence rate per 100 to get the binary events.,FALSE,TRUE,FALSE,TRUE,15196,10904,8432,TEST,B) continuous
251,12426,5614421,severity of any neonatal respiratory disease,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,8,402,7,388,,,,,,FALSE,TRUE,FALSE,TRUE,25930,11480,8549,TEST,B) continuous
109,1884,4188762,withdrawal response of rocuronium,remifentanil,normal saline,binary,0,30,26,30,,,,,Used percentage to calculate events as binary outcome.,FALSE,FALSE,TRUE,TRUE,2068,1758,1564,TEST,B) continuous
89,5538,3912320,Correct response rate for 500 Hz frequency,Occupational noise,Control,continuous,,19,,10,,,,,Mean were in a figure and SD was not given anywhere.,TRUE,FALSE,FALSE,FALSE,1648,1217,1015,TEST,B) continuous
588,11581,115849,patients discontinued due to lack of efficacy,naproxen 500 mg twice daily,placebo,binary,19,181,90,357,,,,,found in fig 1,TRUE,FALSE,FALSE,TRUE,6464,5362,4091,TEST,B) continuous
487,6383,3786549,Baseline characteristics: menopause,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,13.11,7.02,13,6.94,,FALSE,TRUE,FALSE,TRUE,9725,6231,4323,TEST,B) continuous
625,11906,3493722,well compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,8,,4,,,,,,"found in table 2, assumed binary because proportion of whole given",FALSE,TRUE,TRUE,FALSE,1684,1549,1357,TEST,B) continuous
650,13097,5976307,awake time,etomidate,propofol based on midazolam,continuous,,,,,,,,,found in table 2,FALSE,TRUE,TRUE,FALSE,2560,2044,1751,TEST,B) continuous
447,4003,4879328,effects for walking,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.55,2.29,0.31,3.84,Back calculated SD using CI.,FALSE,TRUE,FALSE,TRUE,12872,8442,5640,TEST,B) continuous
579,8566,2952311,State-Trait Anxiety Inventory-I,Acupressure at distal points,Control,continuous,,11,,11,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,3603,2475,2143,TEST,B) continuous
279,6422,3654355,baseline body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,128.9,19.4,127.1,21.6,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
104,1885,4188762,mean blood pressure,remifentanil,normal saline,continuous,,30,,30,,,,,,TRUE,FALSE,TRUE,FALSE,2068,1758,1564,TEST,B) continuous
222,2914,5459456,Lateral bending stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.05,0.02,2.67,0.68,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
394,1120,3577738,enjoyment,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,FALSE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
534,7794,3508963,Pain relief,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,1.13,1.15,2.23,1.57,Values from 30 minutes.,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
379,214,1475568,Hospitalization or death,Follow-up and thorough education on self-care,Standard information about self-care,binary,25,59,39,64,,,,,Used percentage found in table to calculate actual number for binary variable.,FALSE,TRUE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
459,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,20,,20,,,,All numerical values are in a graphical format of table.,FALSE,TRUE,TRUE,FALSE,1396,1236,1068,TEST,B) continuous
201,7738,5380284,Pain scores 24 hours and 72 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,,FALSE,TRUE,TRUE,FALSE,1731,1429,1251,TEST,B) continuous
167,2797,5079604,Disposition index (DI),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,12690,6902,4923,TEST,B) continuous
380,215,1475568,Daily weight monitoring at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,binary,47,59,19,64,,,,,Used percentage found in text to calculate actual number for binary variable.,FALSE,FALSE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
220,2912,5459456,time before eating,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.5,2.2,3.9,2.3,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
24,3244,2972614,Motion range - Shoulder flexion,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,168,22.65,174.31,14.98,Outcome originally just Motion range.,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
259,10575,5711682,rates of death,Genoss drug-eluting stent (DES),Promus Element,binary,1,38,0,39,,,,,,FALSE,TRUE,FALSE,TRUE,13148,4660,2966,TEST,B) continuous
393,1120,3577738,effectiveness,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,FALSE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
646,13025,4675066,The mean language score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,97.2,12.2,97.9,11.5,found in table 2,FALSE,TRUE,FALSE,TRUE,6682,5735,4224,TEST,B) continuous
331,5078,5617873,Parent-rated Aberrant Behavior Checklis improvement,Aripiprazole,Placbeo,continuous,,45,,47,-11.4,1.3,-7.5,1.4,"all means and std found in table 2, given as mean change from baseline",FALSE,TRUE,FALSE,TRUE,7551,5383,4396,TEST,B) continuous
424,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,19.3,10.3,8.2,5.7,,FALSE,TRUE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
338,11078,5655920,vomiting,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,placebo-adjusted meta-analysis (fixed effect) = -0.1,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
210,2913,5459456,inflexion-extension for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.3,1.3,0.2,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
330,5377,5559992,Anxiety,Buprenophine 64 mg,Buprenophine 96 mg,continuous,,4,,5,,,,,found in table,FALSE,TRUE,TRUE,FALSE,1146,884,721,TEST,B) continuous
22,3245,2972614,Shoulder Pain and Disability Index score,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,48.13,22.1,40.99,20.98,,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
310,7833,4541185,onset of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,9.83,1.12,10.85,0.79,found in abstract,FALSE,FALSE,FALSE,TRUE,1359,1043,907,TEST,B) continuous
395,1120,3577738,active trust,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,FALSE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
117,2983,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,No cooling,continuous,,9,,13,,,15.4,,,FALSE,TRUE,TRUE,FALSE,3049,2670,2328,TEST,B) continuous
156,13481,5055753,The mean ¬± SD of intraoperatively administered fentany,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,105,30.8,165,34.5,,FALSE,FALSE,FALSE,TRUE,3292,2470,2114,TEST,B) continuous
363,12884,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,23.1,25.6,98.3,104.6,found in table,FALSE,TRUE,FALSE,TRUE,4402,2905,2274,TEST,B) continuous
252,12427,5614421,other respiratory morbidities,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,,402,,388,,,,,Unclear what measurement to use.,FALSE,FALSE,FALSE,FALSE,25930,11480,8549,TEST,B) continuous
158,7710,5056957,Weight reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,55.91,15.64,56.48,14.76,Back calculated the SD values from CI,FALSE,TRUE,FALSE,TRUE,11185,6045,4394,TEST,B) continuous
33,5575,3003523,Health-related quality of life improvement - Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,This outcome is measured by Short-Form 36-Items (SF-36).,FALSE,FALSE,FALSE,TRUE,12247,10091,7520,TEST,B) continuous
150,11145,4996097,Total nasal resistance,Septoplasty,Control,continuous,,33,,30,0.25,,0.27,,Used preoperative values. SD is not given.,FALSE,TRUE,FALSE,FALSE,9291,4535,2976,TEST,B) continuous
404,2805,5781260,Glutathione peroxidase (GPxP),lemon verbena extract,placebo,continuous,,20,,20,,,,,Mean and CI in figure.,TRUE,FALSE,FALSE,FALSE,4385,3505,2662,TEST,B) continuous
149,11146,4996097,"a"" vowel improvement",Septoplasty,Control,continuous,,33,,30,138,,154,,Used F0 (Hz) values. SD is not given.,FALSE,TRUE,FALSE,FALSE,9291,4535,2976,TEST,B) continuous
223,2914,5459456,Rotation stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.02,0,1.62,0.47,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
324,4727,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,No group sizes and individual means and stds given,FALSE,FALSE,FALSE,FALSE,9850,5076,3578,TEST,B) continuous
281,6422,3654355,baseline fat-free mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,68.3,13.2,67.1,12.8,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
365,12886,5976949,leptin/adiponectin ratio (LAR),"GDM2 (less tight glycaemic targets, <5.3 mmol/L and < 7.8 mmol/L)","GDM1 (tight glycaemic targets, fasting blood glucose_<_5.1_mmol/L and <7.0_mmol/L postprandial) postprandial,), control group- normal glucose tolerance",continuous,,21,,45,1.7,1.66,,,combined means and stds not given,FALSE,TRUE,FALSE,FALSE,4402,2905,2274,TEST,B) continuous
168,2797,5079604,incremental area under the curve for insulin (AUCi),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,12690,6902,4923,TEST,B) continuous
11,9681,2363753,Glomerular filtration rate fall,Amifostine,Control,continuous,,20,,20,10,,37,,Only abstract is available. Full text in PDF only.,FALSE,FALSE,FALSE,FALSE,887,780,725,TEST,B) continuous
494,6484,5419060,Sample rejection rate: CDC D,Phlebotomy training programme,Control,binary,7,630,8,589,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
410,3260,3475525,Correct selection of the healthier product,choices group,No label group,continuous,,98,,99,72.5,13.2,67.8,10.3,Available in abstract and table,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
658,13177,5773985,duration of surgical procedure,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,,,,,,,,Graphic format table,FALSE,TRUE,TRUE,FALSE,2609,2261,1917,TEST,B) continuous
37,6985,3169777,unexpected adverse events,macitentan doses of 0.2 mg,placebo,binary,0,6,0,14,,,,,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,FALSE,FALSE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
289,6103,4215531,MCCB performance : Processing Speed,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,44.6,12.2,48.2,12.3,used post values and Treatment as Usual as Baseline,FALSE,TRUE,FALSE,TRUE,7350,5561,4156,TEST,B) continuous
496,6488,5419060,Request-form errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,11,3973,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
419,3262,3475525,intent of purchase,MTL+caloric intake group,choices group,continuous,,90,,98,3.6,1.5,4.1,1.7,Used values for self.,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
113,9526,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,167.61,83.71,173.28,81.63,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,FALSE,TRUE,FALSE,TRUE,26475,16822,9628,TEST,B) continuous
412,3262,3475525,Taste perception,MTL group,No label group,continuous,,98,,99,5.6,1.4,5.8,1.4,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
359,8711,5971365,Symbol Digit Modalities Test (SDMT) score at week 96,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,720,,682,4.1,12.4,2.9,12.7,"found in figure and text, totals found in figure",TRUE,FALSE,FALSE,TRUE,3177,2394,2130,TEST,B) continuous
51,5308,3195393,Continuous restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,8.5,0.07,10.8,0.13,Overall continuous restraint rate for study site.,FALSE,TRUE,FALSE,TRUE,15527,8380,5589,TEST,B) continuous
212,2913,5459456,lateral bending for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,9.2,0.9,9.6,1.1,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
641,12879,5830087,objective response rate (ORR),"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,29,48,10,23,,,,,found in table 2,FALSE,TRUE,FALSE,TRUE,11942,10628,8141,TEST,B) continuous
134,2449,4574984,Health-Related Quality of Life at 12 month - females,"intervention group, i.e. patient empowerment through information booklet and diary keeping - females","control group, which received standard care - females",continuous,,110,,95,61.07,30.21,63.27,24.79,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,FALSE,FALSE,FALSE,TRUE,12997,7944,5795,TEST,B) continuous
547,8463,3263860,Serious skin reactions,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,Unclear group sizes. Used the group size for 26-week visit.,FALSE,FALSE,TRUE,TRUE,3178,2587,2232,TEST,B) continuous
486,6382,3786549,Improvement in Vaginal Maturation Index,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,35.2,21.7,9.9,14.5,Numerical values based on intention-to-treat,FALSE,TRUE,FALSE,TRUE,9725,6231,4323,TEST,B) continuous
422,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,18.1,11.6,9.3,5.5,,FALSE,TRUE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
209,2913,5459456,inflexion-extension for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,4,0.3,4,0.6,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
30,5576,3003523,Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,Used values for PCS after 52 weeks (final timepoint).,FALSE,TRUE,FALSE,TRUE,12247,10091,7520,TEST,B) continuous
662,13294,4987981,"Psoriasis Area and Severity Index (PASI), Erythema, Scaling and Induration (ESI) and Physician global assessment (PGA) scores",metformin or pioglitazone,placebo,continuous,,37,,23,,,,,Values combined and given in figure,TRUE,FALSE,FALSE,FALSE,9637,7894,5779,TEST,B) continuous
562,9836,3496170,P3a latency,Biperiden,Placebo,continuous,,15,,15,,,,,numerical data in figure.,TRUE,FALSE,TRUE,FALSE,2318,1990,1731,TEST,B) continuous
674,13314,4550271,treatment according to guidelines,provider-school intervention,control,continuous,,14,,12,23.5,26,22.6,23,mean given as percent and std has no unit,FALSE,TRUE,FALSE,TRUE,24886,12978,8556,TEST,B) continuous
118,2984,4323894,Rate of complications,Mild-cooling or deep-cooling,No cooling,binary,,10,,13,,,,,,FALSE,TRUE,TRUE,FALSE,3049,2670,2328,TEST,B) continuous
442,8805,4467620,accuracy of the cognitive tasks,Exercise - Hot + Cooling conditions,At rest - Hot + Cooling conditions,continuous,,8,,8,,,,,,TRUE,FALSE,FALSE,FALSE,7288,4607,3858,TEST,B) continuous
180,10757,5086025,General physical health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.87,11.02,50.46,7.83,,FALSE,TRUE,FALSE,TRUE,29049,17627,13068,TEST,B) continuous
552,9725,3648394,Quality of life - PCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,2.7,46.9,4.8,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",FALSE,TRUE,FALSE,TRUE,9556,6245,4261,TEST,B) continuous
103,1886,4188762,heart rate,remifentanil,ketamine,continuous,,30,,30,,,,,,TRUE,FALSE,TRUE,FALSE,2068,1758,1564,TEST,B) continuous
633,12277,3936115,"Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): ""Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?",Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,17,30,5,22,,,,,found in table 3,FALSE,TRUE,FALSE,TRUE,2217,2016,1562,TEST,B) continuous
131,2451,4574984,numbers overall complications,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,238,326,241,326,,,,,,FALSE,TRUE,FALSE,TRUE,12997,7944,5795,TEST,B) continuous
137,1267,4709985,would have liked more information on acupuncture,tertiary education,other educations,binary,,121,,89,,,,,Specific numbers were not given.,FALSE,FALSE,FALSE,FALSE,3939,3288,2363,TEST,C) unknown - there
309,7833,4541185,onset of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,4.36,0.81,4.84,0.65,found in abstract,FALSE,FALSE,FALSE,TRUE,1359,1043,907,TEST,B) continuous
676,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider-school intervention,control,continuous,,14,,12,56.4,33,64.2,28,mean given as percent and std has no unit,FALSE,TRUE,FALSE,TRUE,24886,12978,8556,TEST,B) continuous
531,7830,4230312,improvement of disorder,quetiapine 600 mg/day,placebo,continuous,,289,,204,-14.88,10.54,-11.61,10.12,Back calculated SD from SE.,TRUE,FALSE,FALSE,TRUE,6201,5058,3918,TEST,B) continuous
629,12234,3510731,Median time in seconds (interquartile range) - Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,25,,25.3,,"found in table 1, IQ range given rather and std",FALSE,TRUE,FALSE,FALSE,1665,1296,943,TEST,B) continuous
154,13480,5055753,the percentages of patients in the agitated sedation scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,TRUE,FALSE,FALSE,FALSE,3292,2470,2114,TEST,B) continuous
655,13175,5773985,mean volume of both the solutions used,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,,,,4.15,0.52,4.12,0.6,Found in abstract and results,FALSE,FALSE,FALSE,FALSE,2609,2261,1917,TEST,B) continuous
326,5373,5559992,Anxiety,Buprenophine 64 mg,No treatment,continuous,,4,,4,,,,,"decided ""no treatment"" meant baseline",FALSE,TRUE,TRUE,FALSE,1146,884,721,TEST,B) continuous
94,10167,4173437,Adverse effects,Tranexamic acid,Control,binary,0,30,0,30,,,,,Had to infer that the group sizes were equal.,FALSE,FALSE,TRUE,TRUE,854,745,637,TEST,B) continuous
656,13176,5773985,subjective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,,,,3,1.08,2.92,1.03,Found in abstract and results,FALSE,FALSE,FALSE,FALSE,2609,2261,1917,TEST,B) continuous
408,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,No label group,continuous,,90,,99,73.3,6.9,67.8,10.3,Available in abstract and table,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
537,7795,3508963,Baseline characteristics - hydronephrosis in left kidney,Intravenous lidocaine,Intravenous morphine,binary,52,120,52,120,,,,,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
468,4802,5515881,memory score,demanding balance training program,relaxation group,continuous,,,,,9.44,5.48,8,4.16,Group sizes are in methods section only. Numerical values are from posttest.,TRUE,TRUE,FALSE,FALSE,4475,3500,2868,TEST,B) continuous
298,5597,4355974,Days limited activity from asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-1.8,,"standard deviations not given, means are mean change",FALSE,TRUE,FALSE,FALSE,7450,5464,3820,TEST,B) continuous
578,8564,2952311,Muscle hardness,Acupressure at local points,Control,continuous,,11,,11,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,3603,2475,2143,TEST,B) continuous
300,5599,4355974,School days missed for asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-0.4,,"standard deviations not given, means are mean change",FALSE,TRUE,FALSE,FALSE,7450,5464,3820,TEST,B) continuous
639,12772,4511433,LDL cholesterol,5 mg elobixibat,placebo,continuous,,12,,12,,,,,no raw values given and can only be estimated from figure,FALSE,FALSE,FALSE,FALSE,4648,3874,2969,TEST,B) continuous
100,930,4183415,Completed treatment,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,Data found in Table 6.,FALSE,TRUE,FALSE,TRUE,10420,7106,5310,TEST,B) continuous
643,12880,5830087,duration of objective response,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,"given as median with confidence interval, cannot calculate",FALSE,TRUE,FALSE,FALSE,11942,10628,8141,TEST,B) continuous
515,6552,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 2400 mg,Control,continuous,,,,,-52.7,,-13.3,,"Group sizes are only in figure, and SD is not available.",TRUE,FALSE,FALSE,FALSE,8206,5593,4514,TEST,B) continuous
147,1273,4880652,"systolic blood pressures at 5, 10, 15, and 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Means in figure 3's graphics.,TRUE,FALSE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
350,4493,5874317,Knee extension (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,237.2,51,182.4,8.4,Found in table raw values,FALSE,TRUE,FALSE,TRUE,10785,5696,4631,TEST,B) continuous
399,2242,4678179,Response rates,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,8,,13,,Only difference in response rates as percent is given.,FALSE,FALSE,FALSE,FALSE,9517,6474,5204,TEST,B) continuous
284,6301,3929816,Baseline characteristics and general anesthesia procedure,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,No quantitative measures given,FALSE,FALSE,FALSE,FALSE,1047,859,749,TEST,B) continuous
569,8557,5541727,Activities of daily living,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,6118,5345,4032,TEST,B) continuous
215,2913,5459456,lateral bending for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2.2,0.4,2,0.3,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
128,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H2 (haloperidol 2 mg),H0 (saline),binary,10,50,21,50,,,,,Used numbers from Late time (2–24 h),FALSE,TRUE,FALSE,TRUE,3932,3205,2434,TEST,B) continuous
295,6104,4215531,MCCB performance : Social Cognition,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,39.3,11.1,42.8,11.7,used post values and Treatment as Usual as Baseline,FALSE,FALSE,FALSE,TRUE,7350,5561,4156,TEST,B) continuous
623,11905,3493722,side effects,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,19,85,32,84,,,,,found in results section,FALSE,FALSE,FALSE,TRUE,1684,1549,1357,TEST,B) continuous
208,2913,5459456,inflexion-extension for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,6.3,1.1,6.5,0.9,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
368,216,1475568,Heart failure-related quality of life at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,1,,5,,Only the mean change was found in text.,FALSE,FALSE,FALSE,FALSE,4361,3649,2573,TEST,B) continuous
560,9834,3496170,Learned irrelevance index,Biperiden,Placebo,continuous,,15,,15,,,,,numerical data in figure.,TRUE,FALSE,TRUE,FALSE,2318,1990,1731,TEST,B) continuous
485,5714,3343759,communication ability,very early speech and language therapy (SLT),control,continuous,,,,,,,,,Unclear outcome.,FALSE,FALSE,FALSE,FALSE,3838,2633,2065,TEST,B) continuous
581,11584,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
533,8166,5800236,Months of sick leave,Nacadia® nature-based therapy,Cognitive behavioral therapy,continuous,,37,,35,,,,,Numerical values were not given for this outcome.,TRUE,FALSE,FALSE,FALSE,4517,2571,1980,TEST,B) continuous
465,4431,5726464,Lipid profile: Triglycerides,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
165,615,5062234,The 24 h morphine requirement,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,34.57,14.64,32.76,14.34,,FALSE,FALSE,TRUE,TRUE,1345,1148,971,TEST,B) continuous
470,4800,5515881,center of pressure (CoP) sway velocity,demanding balance training program,relaxation group,continuous,,,,,0.63,0.11,0.67,0.18,Group sizes are in methods section only. Numerical values are from posttest.,TRUE,TRUE,FALSE,FALSE,4475,3500,2868,TEST,B) continuous
205,5500,5380326,Interleukin 2,Vitamin D supplementation,Control,continuous,,40,,40,4.49,13.34,28.69,103.03,,FALSE,TRUE,FALSE,TRUE,10658,5810,4260,TEST,B) continuous
211,2913,5459456,inflexion-extension for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.1,1.4,0.2,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
173,2791,5079604,The 2-year failure rate,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,13,33,12,15,,,,,Used percentage to calculate events as binary outcome.,TRUE,TRUE,FALSE,TRUE,12690,6902,4923,TEST,B) continuous
197,7734,5380284,Pain scores 48 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,,FALSE,TRUE,TRUE,FALSE,1731,1429,1251,TEST,B) continuous
372,226,1475568,Knowledge about heart failure,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,Only the overall mean difference in score improvement was given.,FALSE,FALSE,FALSE,FALSE,4361,3649,2573,TEST,B) continuous
105,1885,4188762,mean blood pressure,remifentanil,lidocaine,continuous,,30,,30,,,,,,TRUE,FALSE,TRUE,FALSE,2068,1758,1564,TEST,B) continuous
403,2802,5781260,exercise-related loss of muscle strength,lemon verbena extract,placebo,continuous,,20,,20,,,,,Mean and CI in figure.,TRUE,FALSE,FALSE,FALSE,4385,3505,2662,TEST,B) continuous
170,2795,5079604,Cox proportional hazards of failure-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,12690,6902,4923,TEST,B) continuous
253,12427,5614421,"adverse infant outcomes, including serious infant composite outcome",vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,155,406,152,393,,,,,,FALSE,TRUE,FALSE,TRUE,25930,11480,8549,TEST,B) continuous
536,7795,3508963,Baseline characteristics - age,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,35.23,12.37,37.71,11.08,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
521,6697,5154016,Total drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,231.5,18.1,318.5,26.7,,FALSE,TRUE,FALSE,TRUE,3046,2156,1642,TEST,B) continuous
166,616,5062234,intraoperative supplemental fentanyl,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,binary,8,21,16,21,,,,,,FALSE,FALSE,TRUE,TRUE,1345,1148,971,TEST,B) continuous
694,5636,5712123,postoperative pain on movement,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,3.5,,3,,values given as score (range),FALSE,TRUE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
370,218,1475568,Baseline diabetes,Follow-up and thorough education on self-care,Standard information about self-care,binary,35,59,33,64,,,,,Used percentage found in table to calculate actual number for binary variable.,FALSE,TRUE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
390,950,3278655,subsidence,The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,-0.38,0.37,-0.04,0.11,Used numerical values for Superior/inferior translation (SD). Numerical values are from 5-year follow up.,FALSE,TRUE,FALSE,TRUE,5463,3510,2857,TEST,B) continuous
428,3261,3475525,Scores on the saturated fat quiz,MTL group,No label group,continuous,,98,,99,90.7,20.4,33.6,16.3,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
217,2912,5459456,surgery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,67,16,65,13,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
155,13480,5055753,the percentages of patients in the heavily sedated,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,TRUE,FALSE,FALSE,FALSE,3292,2470,2114,TEST,B) continuous
448,4003,4879328,effects for vigorous activity,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.2,1.56,-0.4,2.48,Back calculated SD using CI.,FALSE,TRUE,FALSE,TRUE,12872,8442,5640,TEST,B) continuous
218,2912,5459456,blood loss,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,56,19,51,20,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
148,1274,4880652,Diastolic blood pressures at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Mean in figure 4's graphics.,TRUE,FALSE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
182,4340,5122613,Adverse events,Digestion-resistant maltodextrin,Placebo,binary,0,33,0,33,,,,,Based on abstract.,FALSE,FALSE,FALSE,TRUE,6184,3742,2832,TEST,B) continuous
483,5712,3343759,Amsterdam-Nijmegen everyday language test (ANELT),very early speech and language therapy (SLT),control,continuous,,59,,55,,,,,"Median values are reported. Group size is based on ANELT by day 21, intent-to-treat.",FALSE,TRUE,FALSE,FALSE,3838,2633,2065,TEST,B) continuous
506,6485,5419060,Phlebotomy questionnaire score: CDC D,Phlebotomy training programme,Control,continuous,,23,,23,97,1.21,63,4.31,Back calculated SD using CI,FALSE,FALSE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
26,3244,2972614,Motion range - Shoulder abduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,166.66,21.38,172.72,16.67,Outcome originally just Motion range.,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
441,8804,4467620,weight reduction,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,68.6,7.7,68.8,7.5,The numerical values are from Exercise state.,FALSE,TRUE,FALSE,TRUE,7288,4607,3858,TEST,B) continuous
541,7795,3508963,Baseline characteristics - history of first stone,Intravenous lidocaine,Intravenous morphine,binary,70,120,56,120,,,,,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
516,6554,4033571,Adverse effects,Extended-release oxcarbazepine 2400 mg,Control,binary,85,123,67,121,,,,,,FALSE,TRUE,FALSE,TRUE,8206,5593,4514,TEST,B) continuous
464,4431,5726464,Lipid profile: LDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
193,2094,5360580,Plasma PlsPE,1 mg/day of Pls purified from scallop,placebo,continuous,,138,,131,-0.59,1.11,-0.63,1.08,Data is from after 28 weeks (final timepoint). Back calculated the SD values using CI values.,FALSE,TRUE,FALSE,TRUE,11096,9099,6033,TEST,B) continuous
266,2787,2430617,adverse events,60 µg of YIC,placebo,binary,4,80,4,79,,,,,effects found in abstract and number of samples in text,FALSE,FALSE,FALSE,TRUE,7987,4896,3773,TEST,B) continuous
305,3882,4357072,reappearance of erythematous areas after 2 months posttreatment,pimecrolimus,triamcinolone acetate,binary,1,15,5,15,,,,,significance found in abstract and numbers in results,FALSE,TRUE,FALSE,TRUE,2097,1624,1385,TEST,B) continuous
73,3741,3546023,Urine cotinine levels,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.179,0.738,0.047,0.017,Values are for week 24 (only timepoint after intervention).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
677,13505,5777419,the total cultivable microbiota,probiotic,placebo,continuous,,16,,15,,,,,median and IQ scores given,FALSE,TRUE,FALSE,FALSE,9410,4699,3181,TEST,B) continuous
690,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),reminder card together with the appointment letter (IG2),binary,94,102,91,107,,,,,found in text as fractions of group sizes,FALSE,FALSE,FALSE,TRUE,10493,8112,5695,TEST,B) continuous
575,8562,2952311,Verbal rating scale pain intensity,Acupressure at local points,Control,continuous,,11,,11,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,3603,2475,2143,TEST,B) continuous
524,6741,5325897,Second test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,17.73,0.46,12.13,0.47,,FALSE,FALSE,FALSE,TRUE,4260,2410,1703,TEST,B) continuous
71,3043,3321528,handgrip strength,Intensive Care Unit acquired weakness (ICU-AW),without an ICU-AW diagnosis,continuous,,,,,6.6,4.4,23.4,8.9,Does not have group size information in article.,FALSE,FALSE,FALSE,FALSE,6725,3999,2880,TEST,B) continuous
383,949,3278655,maximum total point motion (MTPM),The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,0.98,3.91,0.79,2.27,Back calculated the SD values from CI. Numerical values are from 5-year follow up.,FALSE,TRUE,FALSE,TRUE,5463,3510,2857,TEST,B) continuous
15,12635,2667135,rate of clinical success at the test-of-cure visit,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,89,103,54,97,,,,,,FALSE,TRUE,FALSE,TRUE,11722,8106,5529,TEST,B) continuous
405,2807,5781260,adverse events,lemon verbena extract,placebo,binary,,20,,20,,,,,Unclear numerical values.,FALSE,FALSE,FALSE,FALSE,4385,3505,2662,TEST,B) continuous
456,4423,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,20,,20,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,TRUE,TRUE,FALSE,1396,1236,1068,TEST,B) continuous
204,5497,5380326,Th1/Th2 cytokines,Vitamin D supplementation,Control,continuous,,40,,40,,,,,Unclear outcome numerical values in the RCT. Cannot clearly identify the actual metric or measure for the given outcome.,FALSE,FALSE,FALSE,FALSE,10658,5810,4260,TEST,B) continuous
241,8053,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),continuous,,12,,12,6,0.9,6.2,1.8,,FALSE,TRUE,FALSE,TRUE,6951,5679,4357,TEST,B) continuous
543,7795,3508963,Baseline characteristics - left kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,63,120,,,,,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
371,228,1475568,Baseline life-quality score,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,Only the mean score was given in table.,FALSE,TRUE,FALSE,FALSE,4361,3649,2573,TEST,B) continuous
285,6302,3929816,Pathologic changes in the liver,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,No quantitative measures given,FALSE,FALSE,FALSE,FALSE,1047,859,749,TEST,B) continuous
675,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider,control,continuous,,14,,12,56.1,31,64.2,28,mean given as percent and std has no unit,FALSE,TRUE,FALSE,TRUE,24886,12978,8556,TEST,B) continuous
291,6103,4215531,MCCB performance : Visual Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,49.4,12.8,46.5,9.8,used post values and Treatment as Usual as Baseline,FALSE,TRUE,FALSE,TRUE,7350,5561,4156,TEST,B) continuous
196,2097,5360580,WMS-R (0 min),1 mg/day of Pls purified from scallop,placebo,continuous,,24,,24,1.29,3.14,1.08,1.55,Data is from 28 weeks (final timepoint). Back calculated the SD values using CI values.,FALSE,TRUE,FALSE,TRUE,11096,9099,6033,TEST,B) continuous
420,3401,3877023,quantitative contour sharpness of the Cervicothoracic Spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,0.95,0.24,1.43,0.48,"Original outcome was ""quantitative contour sharpness"".",FALSE,FALSE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
356,4710,5884950,objective-SCORAD score,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,"mean and std not given, only median and interquartile range",FALSE,FALSE,FALSE,FALSE,11712,6635,5281,TEST,B) continuous
240,8055,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6,0.9,4.8,0.9,,FALSE,TRUE,FALSE,TRUE,6951,5679,4357,TEST,B) continuous
425,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,24,12.9,11.7,6.3,,FALSE,TRUE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
213,2913,5459456,lateral bending for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,5.8,0.5,5.9,0.7,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
341,11080,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,placebo-adjusted meta-analysis (fixed effect) = -0.03,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
671,13313,4550271,Community knowledge,provider,control,continuous,,14,,12,,,,,outcome too broad,FALSE,TRUE,FALSE,FALSE,24886,12978,8556,TEST,B) continuous
123,7936,4486927,the end-of-treatment virologic response,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,83,94,75,93,,,,,,FALSE,TRUE,FALSE,TRUE,14472,7883,5770,TEST,B) continuous
54,5309,3195393,Restraint knowledge,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,6.23,,5.51,,No SD information provided,FALSE,FALSE,FALSE,FALSE,15527,8380,5589,TEST,B) continuous
247,10308,5571493,QT interval,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,No numerical values are given.,FALSE,FALSE,FALSE,FALSE,1507,1019,928,TEST,B) continuous
606,11583,115849,Discontinuation due to lack of efficacy,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
453,4432,5726464,Glucose,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
265,2787,2430617,adverse events,30 µg YIC,placebo,binary,3,83,4,79,,,,,,FALSE,TRUE,FALSE,TRUE,7987,4896,3773,TEST,B) continuous
75,3743,3546023,The percentage of B cells,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,11.97,4,13.72,4.53,Values are between baseline and week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
48,6989,3169777,adverse event profile - headache,macitentan doses of 25 mg,placebo,binary,2,6,3,14,,,,,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",FALSE,TRUE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
510,6486,5419060,Techinque related rejections: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
176,10753,5086025,Psychological flexibility,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,18.23,8.14,22.46,8.67,Actually psychological inflexibility in the article,FALSE,TRUE,FALSE,TRUE,29049,17627,13068,TEST,B) continuous
323,4726,5539943,Motivational Interviewing (MI) knowledge,MI training (MI-AU),baseline,continuous,,,,,,,,,No group sizes and individual means and stds given,FALSE,FALSE,FALSE,FALSE,9850,5076,3578,TEST,B) continuous
684,13506,5777419,reduction of plaque,antibiotic,placebo,continuous,,16,,15,31.8,14.8,27.4,13,found in table 2,FALSE,TRUE,FALSE,TRUE,9410,4699,3181,TEST,B) continuous
507,6486,5419060,Techinque related rejections: CHC A,Phlebotomy training programme,Control,binary,20,10218,20,7557,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
161,7712,5056957,Weight reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,61.08,15.15,61.94,14.25,Back calculated the SD values from CI,FALSE,TRUE,FALSE,TRUE,11185,6045,4394,TEST,B) continuous
608,11584,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
107,1884,4188762,withdrawal response of rocuronium,lidocaine,normal saline,binary,6,30,26,30,,,,,Used percentage to calculate events as binary outcome.,FALSE,FALSE,TRUE,TRUE,2068,1758,1564,TEST,B) continuous
443,8801,4467620,accuracy of the cognitive tasks,Exercise - Hot condition,At rest - Hot condition,continuous,,8,,8,,,,,,TRUE,FALSE,FALSE,FALSE,7288,4607,3858,TEST,B) continuous
312,7835,4541185,drop in mean arterial pressure,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,,,,,found in table,FALSE,TRUE,TRUE,FALSE,1359,1043,907,TEST,B) continuous
78,3740,3546023,tocopherol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.11,3.89,11.39,3.06,Values are between baseline and week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
199,7736,5380284,Rates of POI,Gum-chewing group,No gum group,continuous,,38,,37,,,,,,FALSE,TRUE,TRUE,FALSE,1731,1429,1251,TEST,B) continuous
545,8460,3263860,HbA1c reduction,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,-0.1,0.6,-0.1,0.6,Mean change,FALSE,TRUE,TRUE,TRUE,3178,2587,2232,TEST,B) continuous
108,1884,4188762,withdrawal response of rocuronium,ketamine,normal saline,binary,9,30,26,30,,,,,Used percentage to calculate events as binary outcome.,FALSE,FALSE,TRUE,TRUE,2068,1758,1564,TEST,B) continuous
429,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.3,15.1,33.6,16.3,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
297,5596,4355974,ER visits,BostonBreathes system,Control,binary,1,28,1,14,,,,,found in table,FALSE,TRUE,FALSE,TRUE,7450,5464,3820,TEST,B) continuous
299,5598,4355974,Knowledge,BostonBreathes system,Control,binary,9,12,3,8,,,,,"found in table,",FALSE,TRUE,FALSE,TRUE,7450,5464,3820,TEST,B) continuous
564,9838,3496170,N1 latency,Biperiden,Placebo,continuous,,15,,15,,,,,numerical data in figure.,TRUE,FALSE,TRUE,FALSE,2318,1990,1731,TEST,B) continuous
640,12772,4511433,LDL cholesterol,2.5 mg,placebo,continuous,,12,,12,,,,,no raw values given and can only be estimated from figure,FALSE,FALSE,FALSE,FALSE,4648,3874,2969,TEST,B) continuous
274,6419,3654355,Body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-17.5,6.1,-0.5,2.8,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
439,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,choices group,continuous,,90,,98,94.1,15.6,47.1,21.1,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
95,10163,4173437,Total blood loss,Tranexamic acid,Control,continuous,,30,,30,576,53,823,74,Had to infer that the group sizes were equal.,FALSE,FALSE,TRUE,TRUE,854,745,637,TEST,B) continuous
500,6489,5419060,Preanalytical errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,10,3973,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
502,6489,5419060,Preanalytical errors: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
462,4431,5726464,Lipid profile: total cholesterol,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
92,10164,4173437,Postoperatively hematocrit,Tranexamic acid,Control,continuous,,30,,30,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,TRUE,TRUE,FALSE,854,745,637,TEST,B) continuous
576,8563,2952311,State-Trait Anxiety Inventory-I,Acupressure at local points,Control,continuous,,11,,11,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,3603,2475,2143,TEST,B) continuous
27,3244,2972614,Motion range - Shoulder adduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42,4.27,42.04,5.26,Outcome originally just Motion range.,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
93,10166,4173437,Complications,Tranexamic acid,Control,binary,0,30,0,30,,,,,Had to infer that the group sizes were equal.,FALSE,FALSE,TRUE,TRUE,854,745,637,TEST,B) continuous
435,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.6,15.5,41.9,19.4,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
679,13506,5777419,attachment gain,probiotic,placebo,continuous,,16,,15,3.4,0.6,4.3,1.4,found in table 2,FALSE,TRUE,FALSE,TRUE,9410,4699,3181,TEST,B) continuous
337,11078,5655920,Nausea,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,placebo-adjusted meta-analysis (fixed effect) = -0.1,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
258,10574,5711682,stent thrombosis,Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,FALSE,TRUE,FALSE,TRUE,13148,4660,2966,TEST,B) continuous
584,10215,3504298,Depressive symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,"F-values given, cant use for point estimates",FALSE,FALSE,FALSE,FALSE,4963,4205,3331,TEST,B) continuous
99,929,4183415,patient adherence,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,"Data found in Table 6. Used same values as ""completed treatment",FALSE,TRUE,FALSE,TRUE,10420,7106,5310,TEST,B) continuous
152,13479,5055753,The percentages of patients in the calm,0.2 mg oral clonidine,2 mg oral midazolam,binary,14,40,7,40,,,,,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",FALSE,FALSE,FALSE,TRUE,3292,2470,2114,TEST,B) continuous
81,3740,3546023,tocotrienol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,675.16,150,63.6,5.67,Values are between baseline and week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
195,2096,5360580,"WMS-R (30 min) In the patients aged 77 years or younger,",1 mg/day of Pls purified from scallop,placebo,continuous,,19,,21,1.84,3.87,0,0.96,Data is from 24 weeks (final timepoint). Back calculated the SD values using CI values.,FALSE,TRUE,FALSE,TRUE,11096,9099,6033,TEST,B) continuous
607,11584,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
31,5577,3003523,Short-Form 36-Items improvement,Certolizumab 400 mg,Control,continuous,,390,,199,38.9,8.9,31.5,7.4,Used values for PCS after 52 weeks (final timepoint).,FALSE,TRUE,FALSE,TRUE,12247,10091,7520,TEST,B) continuous
601,11583,115849,Swollen joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
659,13178,5773985,the mean duration of postoperative analgesia,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,,,,508.92,63.3,1840.84,819.51,Found in abstract and results,FALSE,FALSE,FALSE,FALSE,2609,2261,1917,TEST,B) continuous
427,3404,3877023,The mean signal-to-noise (SNR) values,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,44,,49,17.97,6.58,11.28,4.35,,FALSE,FALSE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
35,5579,3003523,Fatigue Assessment Scale improvement,Certolizumab 200 mg,Control,continuous,,393,,199,,,,,Values are in figure.,TRUE,FALSE,FALSE,FALSE,12247,10091,7520,TEST,B) continuous
146,1272,4880652,visual analogue scores,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Mean and SD are in table that is in graphic form.,FALSE,TRUE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
626,11906,3493722,poor compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,2,,3,,,,,,"found in table 2, assumed binary because proportion of whole given",FALSE,TRUE,TRUE,FALSE,1684,1549,1357,TEST,B) continuous
302,3878,4357072,improvement in symptom scores,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,0.2,0.4,0.8,0.6,significance found in abstract and numbers in results,FALSE,TRUE,TRUE,TRUE,2097,1624,1385,TEST,B) continuous
355,4498,5874317,Horizontal triple jump (non-dominant leg),Bilateral training,Unilateral training,continuous,,9,,9,5.71,0.71,5.7,0.45,Found in table raw values,FALSE,TRUE,FALSE,TRUE,10785,5696,4631,TEST,B) continuous
491,6484,5419060,Sample rejection rate: CHC A,Phlebotomy training programme,Control,binary,79,10218,60,7557,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
628,12233,3510731,Clicked on Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,202,6051,362,5892,,,,,found in table 1,FALSE,TRUE,FALSE,TRUE,1665,1296,943,TEST,B) continuous
125,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H0 (saline),continuous,,50,,50,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,3932,3205,2434,TEST,B) continuous
162,7712,5056957,BMI reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,21.86,6.22,22.06,5.68,Back calculated the SD values from CI,FALSE,TRUE,FALSE,TRUE,11185,6045,4394,TEST,B) continuous
157,13482,5055753,Mean ± SD of heart rate,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,,,,,Info in figure graphics.,TRUE,FALSE,FALSE,FALSE,3292,2470,2114,TEST,B) continuous
492,6484,5419060,Sample rejection rate: CHC B,Phlebotomy training programme,Control,binary,48,4114,45,3973,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
474,5522,4144850,Independent household latrines number,Total Sanitation Campaign,Control,binary,673,"1,525",366,"1,514",,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
69,3041,3321528,knee extension,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,Only median and interquartile range is given.,FALSE,TRUE,FALSE,FALSE,6725,3999,2880,TEST,B) continuous
74,3742,3546023,serum α1-antitrypsin,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.75,0.39,1.45,0.24,Values are for week 24 (only timepoint after intervention).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
566,8556,5541727,Knee Injury and Osteoarthritis Outcome Score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,6118,5345,4032,TEST,B) continuous
84,13566,3687098,adverse event of constipation,sitagliptin 100 mg/day,comparator agent,binary,178,7726,124,6885,,,,,Used incidence rate per 100 to get the binary events.,FALSE,TRUE,FALSE,TRUE,15196,10904,8432,TEST,B) continuous
68,3041,3321528,hip flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,Only median and interquartile range is given.,FALSE,TRUE,FALSE,FALSE,6725,3999,2880,TEST,B) continuous
559,9833,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Casein shake (Placebo),continuous,,12,,16,-4,12.35,-8,65.41,From per protocol,FALSE,TRUE,FALSE,TRUE,6022,3786,2937,TEST,B) continuous
498,6488,5419060,Request-form errors: CDC D,Phlebotomy training programme,Control,binary,0,630,0,589,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
357,4711,5884950,chemokines CXCL9,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,"mean and std not given, only median and interquartile range",FALSE,FALSE,FALSE,FALSE,11712,6635,5281,TEST,B) continuous
526,6916,4411165,tympanic temperature from Pre to P20 (-0.28 ±0.11°C),"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-0.28,0.11,-0.14,0.05,Values on mean change are based on what is reported in abstract.,TRUE,FALSE,FALSE,TRUE,3146,2589,2336,TEST,B) continuous
172,2790,5079604,Hyperglycemia relapse-free survival,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,12690,6902,4923,TEST,B) continuous
322,4726,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,No group sizes and individual means and stds given,FALSE,FALSE,FALSE,FALSE,9850,5076,3578,TEST,B) continuous
509,6486,5419060,Techinque related rejections: CDC C,Phlebotomy training programme,Control,binary,18,2279,15,2321,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
391,951,3278655,"The proportion of ""at risk"" components at 5 years",The trabecular metal tibial monoblock component (TM),cemented component.,binary,0,27,2,18,,,,,Used numerical values from 5-year follow up provided in abstract.,FALSE,FALSE,FALSE,TRUE,5463,3510,2857,TEST,B) continuous
163,7713,5056957,BMI z-score at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,0.69,1.81,0.71,1.63,Back calculated the SD values from CI,FALSE,TRUE,FALSE,TRUE,11185,6045,4394,TEST,B) continuous
214,2913,5459456,lateral bending for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2,0.4,1.8,0.2,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
143,1272,4880652,"oxygen saturation at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Means in figure 5's graphics.,TRUE,FALSE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
480,4801,5515881,VO2peak,demanding balance training program,relaxation group,continuous,,,,,32.07,6.52,31.947,7.89,Group sizes are in methods section only. Numerical values are from posttest.,TRUE,TRUE,FALSE,FALSE,4475,3500,2868,TEST,B) continuous
203,5496,5380326,Vitamin D levels,Vitamin D supplementation,Control,continuous,,40,,40,45.93,15.37,21.87,5.31,,FALSE,TRUE,FALSE,TRUE,10658,5810,4260,TEST,B) continuous
362,8714,5971365,clinically meaningful improvement at week 96 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,432,720,369,682,,,,,"counts calculated from percentages given in text, totals found in figure",TRUE,FALSE,FALSE,TRUE,3177,2394,2130,TEST,B) continuous
364,12885,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)","GDM2 (less tight glycaemic targets, <5.3_mmol/L and <_7.8_mmol/L)",continuous,,20,,21,23.1,25.6,21.5,25.8,found in table,FALSE,TRUE,FALSE,TRUE,4402,2905,2274,TEST,B) continuous
303,3879,4357072,reduction in burning sensation,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,1,2.1,5.3,6.1,significance found in abstract and numbers in results,FALSE,TRUE,TRUE,TRUE,2097,1624,1385,TEST,B) continuous
421,3401,3877023,quantitative contour sharpness of the thoracolumbar spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,0.83,0.22,1.32,0.51,"Original outcome was ""quantitative contour sharpness"".",FALSE,FALSE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
319,4723,5539943,reflections of sustain talk,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,No group sizes and individual means and stds given,FALSE,FALSE,FALSE,FALSE,9850,5076,3578,TEST,B) continuous
358,8710,5971365,clinically meaningful improvement at week 144 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,188,287,144,277,,,,,"counts calculated from percentages given in text, totals found in figure",FALSE,FALSE,FALSE,TRUE,3177,2394,2130,TEST,B) continuous
66,1643,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,14,23,4,19,,,,,Used percentage to calculate events as binary outcome.,FALSE,FALSE,TRUE,TRUE,1437,1263,1073,TEST,B) continuous
332,5079,5617873,Clinician-rated Clinical Global Impression-Improvement scores,Aripiprazole,Placbeo,continuous,,47,,45,2.4,0.1,3.4,0.1,raw values foun din text,FALSE,FALSE,FALSE,TRUE,7551,5383,4396,TEST,B) continuous
360,8712,5971365,Symbol Digit Modalities Test (SDMT) score at week 144 in limited patients,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,287,,277,6.3,12.6,3.1,13.2,"found in figure and text, totals found in figure",FALSE,FALSE,FALSE,TRUE,3177,2394,2130,TEST,B) continuous
10,9682,2363753,Grade III/IV stomatitis,Amifostine,Control,binary,0,20,5,20,,,,,Only abstract is available. Full text in PDF only.,FALSE,FALSE,FALSE,TRUE,887,780,725,TEST,B) continuous
46,6989,3169777,adverse event profile - headache,macitentan doses of 1 mg,placebo,binary,0,6,3,14,,,,,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",FALSE,TRUE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
369,217,1475568,Baseline hypertension,Follow-up and thorough education on self-care,Standard information about self-care,binary,51,59,57,64,,,,,Used percentage found in table to calculate actual number for binary variable.,FALSE,TRUE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
617,11602,1863515,absolute neutrophil count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-485,,0,,"given as estimated change and no std given, also in figure and graphic format",TRUE,TRUE,TRUE,FALSE,3963,3457,3103,TEST,B) continuous
171,2793,5079604,The restricted mean time to hyperglycemia relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,480,,305,,SD is not given.,FALSE,FALSE,FALSE,FALSE,12690,6902,4923,TEST,B) continuous
587,11581,115849,patients discontinued due to lack of efficacy,etoricoxib 90 mg once daily,placebo,binary,44,353,90,357,,,,,found in fig 1,TRUE,FALSE,FALSE,TRUE,6464,5362,4091,TEST,B) continuous
242,8056,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6.2,1.8,4.8,0.9,,FALSE,TRUE,FALSE,TRUE,6951,5679,4357,TEST,B) continuous
475,5523,4144850,Open defecation - adult men,Total Sanitation Campaign,Control,binary,1138,"1,525",1273,"1,514",,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
654,13101,5976307,The incidence rate of myoclonus,etomidate,propofol based on midazolam,binary,,,,,,,,,found in table 3,FALSE,TRUE,TRUE,FALSE,2560,2044,1751,TEST,B) continuous
398,2241,4678179,Median overall survival (OS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,6.9,4.09,6.1,5.57,"Median is given with CI. Since the outcome explicitly says ""median"", including median values. Back calculated SD using CI.",FALSE,FALSE,FALSE,TRUE,9517,6474,5204,TEST,B) continuous
663,13295,4987981,percentage of patients achieving 75 % reduction in PASI and ESI scores,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,Values combined and given in figure,TRUE,FALSE,FALSE,FALSE,9637,7894,5779,TEST,B) continuous
151,11147,4996097,"n"" consonant improvement",Septoplasty,Control,continuous,,33,,30,11897,,13229,,Used F0 (Hz) values. SD is not given.,FALSE,TRUE,FALSE,FALSE,9291,4535,2976,TEST,B) continuous
574,8565,2952311,Verbal rating scale pain intensity,Acupressure at distal points,Control,continuous,,11,,11,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,3603,2475,2143,TEST,B) continuous
311,7834,4541185,drop in heart rate,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,,,,,found in table,FALSE,TRUE,TRUE,FALSE,1359,1043,907,TEST,B) continuous
333,5080,5617873,Serious adverse effects,Aripiprazole,Placbeo,binary,0,47,1,45,,,,,all means and std found in table 2,FALSE,TRUE,FALSE,TRUE,7551,5383,4396,TEST,B) continuous
342,11080,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,placebo-adjusted meta-analysis (fixed effect) = -0.03,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
631,12275,3936115,The number of diverticulitis clinical symptom occurrences during 12months,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,2,30,7,22,,,,,found in table 1,FALSE,TRUE,FALSE,TRUE,2217,2016,1562,TEST,B) continuous
455,4422,4483334,Amount of calcium and phosphate on enamel surface,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,20,,20,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,TRUE,TRUE,FALSE,1396,1236,1068,TEST,B) continuous
361,8713,5971365,clinically meaningful worsening at week 96 (⩾3-point decrease on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,140,720,169,682,,,,,"counts calculated from percentages given in text, totals found in figure",TRUE,FALSE,FALSE,TRUE,3177,2394,2130,TEST,B) continuous
29,3244,2972614,Motion range - Shoulder external rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,44.83,5.64,44.09,1.97,Outcome originally just Motion range.,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
385,1118,3577738,website use in terms of the number of pages visited,website with social presence elements.,website without social presence elements.,continuous,,,,,7.5,4,8,3.8,Cannot find the group sizes in the text or table.,FALSE,TRUE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
401,2723,5268424,score on the general dimension scale of negative affects (referred to as NA from here onward),view a video featuring individuals that live in extreme poverty,control,continuous,,55,,50,21.036,6.327,17.68,5.859,,FALSE,TRUE,FALSE,TRUE,12258,6615,4148,TEST,B) continuous
573,8561,5541727,lateral tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-3.7,3.4,-0.8,3.5,Values are from 24 months,FALSE,TRUE,FALSE,TRUE,6118,5345,4032,TEST,B) continuous
335,5082,5617873,Social withdrawal,Aripiprazole,Placbeo,continuous,,45,,47,-4.7,1.1,-5.2,1,"table 2, given as mean change",FALSE,TRUE,FALSE,TRUE,7551,5383,4396,TEST,B) continuous
505,6485,5419060,Phlebotomy questionnaire score: CDC C,Phlebotomy training programme,Control,continuous,,23,,23,97,3.85,60,5.25,Back calculated SD using CI,FALSE,FALSE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
450,4005,4879328,weekly moderate physical activity sessions,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.19,1.82,-0.68,2.32,Back calculated SD using CI.,FALSE,TRUE,FALSE,TRUE,12872,8442,5640,TEST,B) continuous
138,3101,4830045,Birth status,Patients in the 3h group,Patients in the 20h group,binary,32,74,22,60,,,,,Used numbers for live birth rate.,FALSE,TRUE,FALSE,TRUE,2530,2096,1505,TEST,B) continuous
488,6383,3786549,Baseline characteristics: height,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,154.86,5.45,153.43,5.88,,FALSE,TRUE,FALSE,TRUE,9725,6231,4323,TEST,B) continuous
348,10235,5686687,Prolactin levels,Resveratrol,Placebo,continuous,,22,,22,,,,,median and ranges given,FALSE,TRUE,FALSE,FALSE,7451,3515,2366,TEST,B) continuous
538,7795,3508963,Baseline characteristics - hydronephrosis in right kidney,Intravenous lidocaine,Intravenous morphine,binary,57,120,53,120,,,,,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
685,13760,2836833,Fecal fat loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,TRUE,FALSE,FALSE,12992,7163,5694,TEST,B) continuous
50,6989,3169777,adverse event profile - headache,macitentan doses of 300 mg,placebo,binary,2,6,3,14,,,,,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",FALSE,TRUE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
304,3880,4357072,reduction in erythematous area,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,binary,14,15,10,15,,,,,significance found in abstract and numbers in results,FALSE,TRUE,TRUE,TRUE,2097,1624,1385,TEST,B) continuous
624,11906,3493722,good compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,74,,74,,,,,,"found in table 2, assumed binary because proportion of whole given",FALSE,TRUE,TRUE,FALSE,1684,1549,1357,TEST,B) continuous
651,13098,5976307,The incidence rate of all cardiopulmonary adverse events,etomidate,propofol based on midazolam,binary,,,,,,,,,found in table 3,FALSE,TRUE,TRUE,FALSE,2560,2044,1751,TEST,B) continuous
604,11583,115849,Serum C-reactive protein,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
582,10219,3504298,Attentional Function,Word-based attentional bias modification,Face-based attentional bias modification,continuous,,16,,16,,,,,"F-values given, cant use for point estimates, and values in figure",TRUE,FALSE,FALSE,FALSE,4963,4205,3331,TEST,B) continuous
288,6102,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,treatment as usual (TAU),continuous,,19,,19,,,,,"F-values given, not sure how to use them",FALSE,FALSE,FALSE,FALSE,7350,5561,4156,TEST,B) continuous
343,11081,5655920,Hypoglycaemia,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,placebo-adjusted meta-analysis (fixed effect) = -0.02,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
652,13099,5976307,The incidence rate of vital sign fluctuation (VSF),etomidate,propofol based on midazolam,binary,,,,,,,,,found in table 3,FALSE,TRUE,TRUE,FALSE,2560,2044,1751,TEST,B) continuous
402,2804,5781260,Exercise-induced Creatine kinase (CK),lemon verbena extract,placebo,continuous,,20,,20,,,,,Mean and CI in figure.,TRUE,FALSE,FALSE,FALSE,4385,3505,2662,TEST,B) continuous
178,10755,5086025,Binge eating,Intuitive Eating and Acceptance and Commitment Therapy,Control,binary,7,26,14,26,,,,,,FALSE,FALSE,FALSE,TRUE,29049,17627,13068,TEST,B) continuous
451,4006,4879328,accelerometer-assessed moderate to vigorous physical activity (MVPA),"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,99,,108,7.41,66.12,-16.1,66.25,Values are from Accelerometer PA in Table 2. Back calculated SD using CI.,FALSE,TRUE,FALSE,TRUE,12872,8442,5640,TEST,B) continuous
321,4725,5539943,"Frequency of client ""change talk"" (CT)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,No group sizes and individual means and stds given,FALSE,FALSE,FALSE,FALSE,9850,5076,3578,TEST,B) continuous
642,12880,5830087,disease control rate,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,45,48,21,23,,,,,found in table 2,FALSE,TRUE,FALSE,TRUE,11942,10628,8141,TEST,B) continuous
553,9725,3648394,Quality of life - MCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,10.6,48.5,7.7,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",FALSE,TRUE,FALSE,TRUE,9556,6245,4261,TEST,B) continuous
129,4927,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,H0 (saline),"H1(haloperidol 1 mg),",continuous,,50,,49,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,3932,3205,2434,TEST,B) continuous
169,2792,5079604,hyperglycemia relapse-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,12690,6902,4923,TEST,B) continuous
444,8802,4467620,differences in the accuracy,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,,,,,,TRUE,FALSE,FALSE,FALSE,7288,4607,3858,TEST,B) continuous
96,10165,4173437,Coagulation profile,Tranexamic acid,Control,continuous,,30,,30,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,TRUE,TRUE,FALSE,854,745,637,TEST,B) continuous
293,6104,4215531,MCCB performance : Verbal Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.1,10,47.3,10.4,used post values and Treatment as Usual as Baseline,FALSE,TRUE,FALSE,TRUE,7352,5561,4156,TEST,B) continuous
382,876,2974815,discontinued treatment,"phone calls"" group","no phone calls"" group",binary,4,108,30,246,,,,,Values from results section text.,FALSE,FALSE,FALSE,TRUE,13659,6016,4469,TEST,B) continuous
637,12720,4132222,decrease in average lesion,application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,no raw values given and can only be estimated from figure,FALSE,FALSE,FALSE,FALSE,2177,1885,1617,TEST,B) continuous
400,2243,4678179,rate of adverse events,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),binary,4,53,2,53,,,,,Used numbers found in results section text.,FALSE,FALSE,FALSE,TRUE,9517,6474,5204,TEST,B) continuous
440,8803,4467620,decrease in exercise intensity as time elapsed (at time 10),Hot + Cooling conditions,Hot conditions,continuous,,8,,8,114.6,35.6,123.9,30.2,Added the last timepoint to the outcome name. Since there are 10 different time points.,FALSE,TRUE,FALSE,TRUE,7288,4607,3858,TEST,B) continuous
605,11583,115849,ACR20 responder criteria,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
276,6421,3654355,Visceral fat,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-82.3,31.6,4.3,22.7,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
527,6918,4411165,systolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,Numerical values are only in the figures.,TRUE,FALSE,FALSE,FALSE,3146,2589,2336,TEST,B) continuous
239,8054,5534041,composite z-scores in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.11,0.81,-0.25,0.71,,FALSE,TRUE,FALSE,TRUE,6951,5679,4357,TEST,B) continuous
7,11452,1574360,the average cost of the food,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.63,0.4,0.62,0.36,Have to use CI to calculate the SDs,FALSE,FALSE,TRUE,TRUE,1959,1620,1376,TEST,B) continuous
219,2912,5459456,recovery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.1,2,3.5,1.4,,FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
530,6917,4411165,Tskin of the head,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,Numerical values are only in the figures.,TRUE,FALSE,FALSE,FALSE,3146,2589,2336,TEST,B) continuous
525,6742,5325897,Final test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,18.53,0.22,18.99,0.22,,FALSE,FALSE,FALSE,TRUE,4260,2410,1703,TEST,B) continuous
245,10307,5571493,Glycemic level,Saline + Quinine infusion,Dw 5% + Quinine infusion,continuous,,10,,10,0.74,0.05,0.82,0.05,,FALSE,FALSE,FALSE,TRUE,1507,1019,928,TEST,B) continuous
478,5525,4144850,Helminth infections,Total Sanitation Campaign,Control,binary,34,581,32,569,,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
290,6103,4215531,MCCB performance : Attentional Vigilance,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,38.5,11.8,41.3,10.1,used post values and Treatment as Usual as Baseline,FALSE,TRUE,FALSE,TRUE,7350,5561,4156,TEST,B) continuous
479,5526,4144850,Anemia,Total Sanitation Campaign,Control,binary,"1,078","1,919",976,"1,922",,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
467,4434,5726464,Metabolic syndrome,Vitamin D plus calcium supplementation,Placebo,binary,9,66,11,75,,,,,,FALSE,TRUE,FALSE,TRUE,6563,4244,3133,TEST,B) continuous
102,1886,4188762,heart rate,remifentanil,lidocaine,continuous,,30,,30,,,,,,TRUE,FALSE,TRUE,FALSE,2068,1758,1564,TEST,B) continuous
599,11583,115849,investigator global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
62,1642,3309311,differences in the LDD,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,23,23,9,19,,,,,Used percentage to calculate events as binary outcome. Outcome original HDD but changed to LDD to fix typo,FALSE,TRUE,TRUE,TRUE,1437,1263,1073,TEST,B) continuous
13,12633,2667135,proportion of patients completed therapy,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,93,103,44,97,,,,,,FALSE,TRUE,FALSE,TRUE,11722,8106,5529,TEST,B) continuous
477,5523,4144850,Open defecation - children,Total Sanitation Campaign,Control,binary,1279,"1,525",1350,"1,514",,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
377,222,1475568,Baseline digoxin intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,25,59,19,64,,,,,Used percentage found in table to calculate actual number for binary variable.,FALSE,TRUE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
697,5639,5712123,morphine requirements,D/E group,P group,continuous,,30,,30,,,,,found in fig3,TRUE,FALSE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
598,11583,115849,Patient global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
529,6915,4411165,effects of cryostimulation on the ANS - heart rate,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-7.7,2.3,-5.02,1.07,"Changed from original outcome but adding ""- heart rate"" to make it more specific. Numbers are mean change.",TRUE,FALSE,FALSE,TRUE,3146,2589,2336,TEST,B) continuous
270,2991,3214395,bronchospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 47",group 3 involved bispectral index (BIS) of 37,binary,,60,,30,,,,,,FALSE,TRUE,TRUE,FALSE,1201,996,880,TEST,B) continuous
47,6989,3169777,adverse event profile - headache,macitentan doses of 5 mg,placebo,binary,0,6,3,14,,,,,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",FALSE,TRUE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
446,4002,4879328,waist circumference,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.32,0.3,3.54,Back calculated SD using CI.,FALSE,TRUE,FALSE,TRUE,12872,8442,5640,TEST,B) continuous
280,6422,3654355,baseline fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,60.5,11,60.4,13.5,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
481,5521,4144850,Sanitation facility improvement,Total Sanitation Campaign,Control,binary,630,"1,522",342,"1,512",,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
592,11583,115849,Swollen joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
460,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,20,,20,,,,All numerical values are in a graphical format of table.,FALSE,TRUE,TRUE,FALSE,1396,1236,1068,TEST,B) continuous
645,13025,4675066,The mean cognitive score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,99.4,12.2,101.7,8.2,found in table 2,FALSE,TRUE,FALSE,TRUE,6682,5735,4224,TEST,B) continuous
273,2991,3214395,awakening,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 50",group 3 involved bispectral index (BIS) of 40,continuous,,60,,30,,,,,mean and std not given for group 1 and 2 combined,FALSE,TRUE,TRUE,FALSE,1201,996,880,TEST,B) continuous
613,11584,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
466,4433,5726464,Changes in body mass index,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
115,9524,4319071,Fruit intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,2.17,1.71,2.14,1.71,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,FALSE,TRUE,FALSE,TRUE,26475,16822,9628,TEST,B) continuous
653,13100,5976307,the incidence rate of adverse events disturbing the procedure,etomidate,propofol based on midazolam,binary,,,,,,,,,found in table 3,FALSE,TRUE,TRUE,FALSE,2560,2044,1751,TEST,B) continuous
70,3041,3321528,ankle dorsiflexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,Only median and interquartile range is given.,FALSE,TRUE,FALSE,FALSE,6725,3999,2880,TEST,B) continuous
501,6489,5419060,Preanalytical errors: CDC C,Phlebotomy training programme,Control,binary,10,2279,15,2321,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
416,3262,3475525,intent of purchase,MTL group,No label group,continuous,,98,,99,3.8,1.4,4.1,1.5,Used values for self.,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
246,10305,5571493,Glycemic level,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,0.74,0.05,0.83,0.05,,FALSE,FALSE,FALSE,TRUE,1507,1019,928,TEST,B) continuous
40,6985,3169777,unexpected adverse events,macitentan doses of 25 mg,placebo,binary,0,6,0,14,,,,,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,FALSE,FALSE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
65,1644,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)",adults with LBP with radicular pain (group C),binary,14,23,3,18,,,,,Used percentage to calculate events as binary outcome.,FALSE,FALSE,TRUE,TRUE,1437,1263,1073,TEST,B) continuous
374,227,1475568,Self-efficacy,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,Only the overall mean difference in score improvement was given.,FALSE,FALSE,FALSE,FALSE,4361,3649,2573,TEST,B) continuous
378,221,1475568,Baseline angiotensin-converting enzyme (ACE) inhibitors intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,Unclear since the values for this are reported with ARB intake.,FALSE,TRUE,FALSE,FALSE,4361,3649,2573,TEST,B) continuous
664,13296,4987981,FPG,metformin,placebo,continuous,,21,,23,101.9,35.1,97.6,20.8,Values seperated and found in table,FALSE,TRUE,FALSE,TRUE,9637,7894,5779,TEST,B) continuous
680,13506,5777419,reduction of PPD,probiotic,placebo,continuous,,16,,15,2.2,0.3,2.5,0.6,found in table 2,FALSE,TRUE,FALSE,TRUE,9410,4699,3181,TEST,B) continuous
518,6699,5154016,Second 24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,53.7,3.8,63.5,14.2,,FALSE,TRUE,FALSE,TRUE,3046,2156,1642,TEST,B) continuous
283,6422,3654355,baseline visceral fat area,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,255.7,64.7,245.6,66.3,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
250,12425,5614421,The incidence of respiratory distress syndrome,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,42,402,41,388,,,,,,FALSE,TRUE,FALSE,TRUE,25930,11480,8549,TEST,B) continuous
583,10218,3504298,Difference of cortisol on waking and the highest level of following samples,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,"F-values given, cant use for point estimates, and values in figure",TRUE,FALSE,FALSE,FALSE,4963,4205,3331,TEST,B) continuous
206,5499,5380326,Dipeptidyl peptidase-4,Vitamin D supplementation,Control,continuous,,40,,40,"6,032.37",1359.15,6408.33,1822.17,Table and text has conflicting numbers. Values are from Table.,FALSE,FALSE,FALSE,TRUE,10658,5810,4260,TEST,B) continuous
665,13296,4987981,FPG,pioglitazone,placebo,continuous,,16,,23,103.4,28.9,97.6,20.8,Values seperated and found in table,FALSE,TRUE,FALSE,TRUE,9637,7894,5779,TEST,B) continuous
532,7829,4230312,improvement of disorder,quetiapine 300 mg/day,placebo,continuous,,283,,204,-15.58,10.43,-11.61,10.12,Back calculated SD from SE.,TRUE,FALSE,FALSE,TRUE,6201,5058,3918,TEST,B) continuous
64,1642,3309311,differences in the HIZ,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,14,23,4,19,,,,,Used percentage to calculate events as binary outcome.,FALSE,TRUE,TRUE,TRUE,1437,1263,1073,TEST,B) continuous
591,11583,115849,Tender joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
114,9523,4319071,Fruit intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.17,1.71,2,1.67,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,FALSE,TRUE,FALSE,TRUE,26475,16822,9628,TEST,B) continuous
248,10309,5571493,QT interval,Dw 5%+ Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,,,,,No numerical values are given.,FALSE,FALSE,FALSE,FALSE,1507,1019,928,TEST,B) continuous
551,9724,3648394,Push-up test,10-week yoga program,Control,continuous,,18,,19,21,11,20,13,Numerical values are from Week 11.,FALSE,TRUE,FALSE,TRUE,9556,6245,4261,TEST,B) continuous
472,5710,3343759,improvment in ANELT by day 21,higher level of education (>12 years),<12 years of education,continuous,,,,,,,,,Median is reported. Group sizes are only available in methods section.,FALSE,TRUE,FALSE,FALSE,3838,2633,2065,TEST,B) continuous
445,4098,4140238,ocular itching for visit 3B at 7 min,bepotastine besilate ophthalmic solution (BBOS) 1.5%,placebo,continuous,,70,,70,1.2,,2.1,,"Original outcome name is ""ocular itching"". However, due to many different visits and data from timepoints. We specified this in the outcome. Visit 3B was the first study they conducted and 7 min is the last timepoint. No SD information was given",FALSE,TRUE,FALSE,FALSE,12685,6812,5052,TEST,B) continuous
142,1272,4880652,systolic pressures at 0 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Mean in figure 3's graphics.,TRUE,FALSE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
286,6303,3929816,Pathologic changes in the kidneys,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,20,,,,Not enough measures given for calculation,FALSE,FALSE,FALSE,FALSE,1047,859,749,TEST,B) continuous
339,11079,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
336,5083,5617873,Compulsion scale,Aripiprazole,Placbeo,continuous,,45,,47,-1.3,0.5,-2,0.5,"table 2, given as mean change",FALSE,TRUE,FALSE,TRUE,7551,5383,4396,TEST,B) continuous
597,11583,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
612,11584,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
520,6696,5154016,24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,185.2,68,230.8,75,,FALSE,TRUE,FALSE,TRUE,3046,2156,1642,TEST,B) continuous
127,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H0 (saline),binary,11,49,21,50,,,,,Used numbers from Late time (2–24 h),FALSE,TRUE,FALSE,TRUE,3932,3205,2434,TEST,B) continuous
540,7795,3508963,Baseline characteristics - history of reurrent stone,Intravenous lidocaine,Intravenous morphine,binary,49,120,64,120,,,,,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
386,1118,3577738,website use in terms of time on the website,website with social presence elements.,website without social presence elements.,continuous,,,,,151,117.4,150.8,107.8,Cannot find the group sizes in the text or table.,FALSE,TRUE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
603,11583,115849,Health Assessment Questionnaire disability,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
139,3100,4830045,Embryo quality,Patients in the 3h group,Patients in the 20h group,binary,,74,,60,,,,,Unclear outcome measures.,FALSE,FALSE,FALSE,FALSE,2530,2096,1505,TEST,B) continuous
307,7831,4541185,duration of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,621.67,46.76,500.86,44.58,found in text,FALSE,TRUE,TRUE,TRUE,1359,1043,907,TEST,B) continuous
546,8461,3263860,Severe hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,binary,3,73,5,71,,,,,,FALSE,TRUE,TRUE,TRUE,3178,2587,2232,TEST,B) continuous
194,2095,5360580,occurrence of adverse events,1 mg/day of Pls purified from scallop,placebo,binary,39,169,35,167,,,,,,FALSE,TRUE,FALSE,TRUE,11096,9099,6033,TEST,B) continuous
484,5713,3343759,history of myocardial infarction,very early speech and language therapy (SLT),control,binary,,,,,,,,,Numerical data are only in methods section.,FALSE,TRUE,FALSE,FALSE,3838,2633,2065,TEST,B) continuous
25,3244,2972614,Motion range - Shoulder extension,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42.66,3.4,42.95,3.98,Outcome originally just Motion range.,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
43,6985,3169777,unexpected adverse events,macitentan doses of 600 mg,placebo,binary,0,6,0,14,,,,,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,FALSE,FALSE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
497,6488,5419060,Request-form errors: CDC C,Phlebotomy training programme,Control,binary,6,2279,3,2321,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
686,13761,2836833,Urinary calcium excretion,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,TRUE,FALSE,FALSE,12992,7163,5694,TEST,B) continuous
615,11602,1863515,haemoglobin level between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-0.4,,0,,"given as estimated change and no std given, also in figure and graphic format",TRUE,TRUE,TRUE,FALSE,3963,3457,3103,TEST,B) continuous
406,2803,5781260,Movement induced pain (VAS),lemon verbena extract,placebo,continuous,,20,,20,,,,,Mean and CI in figure.,FALSE,FALSE,FALSE,FALSE,4385,3505,2662,TEST,B) continuous
45,6989,3169777,adverse event profile - headache,macitentan doses of 0.2 mg,placebo,binary,0,6,3,14,,,,,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",FALSE,TRUE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
572,8561,5541727,medial tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-1.4,4.2,-3.3,5.3,Values are from 24 months,FALSE,TRUE,FALSE,TRUE,6118,5345,4032,TEST,B) continuous
627,12232,3510731,Clicked on Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,247,6051,515,5892,,,,,found in table 1,FALSE,TRUE,FALSE,TRUE,1665,1296,943,TEST,B) continuous
499,6489,5419060,Preanalytical errors: CHC A,Phlebotomy training programme,Control,binary,27,10218,17,7557,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
580,10217,3504298,Anxious symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,"F-values given, cant use for point estimates, and values in figure",TRUE,FALSE,FALSE,FALSE,4963,4205,3331,TEST,B) continuous
327,5374,5559992,Anxiety,Buprenophine 96 mg,No treatment,continuous,,5,,5,,,,,"decided ""no treatment"" meant baseline",FALSE,TRUE,TRUE,FALSE,1146,884,721,TEST,B) continuous
345,10232,5686687,Pain,Resveratrol,Placebo,continuous,,22,,22,2.3,2.63,3.9,3.35,Back calculated the SD values from CI.,FALSE,TRUE,FALSE,TRUE,7451,3515,2366,TEST,B) continuous
16,12636,2667135,deaths,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,4,103,18,97,,,,,,FALSE,TRUE,FALSE,TRUE,11722,8106,5529,TEST,B) continuous
198,7735,5380284,Surgery duration,Gum-chewing group,No gum group,continuous,,38,,37,,,,,Data is unavailable.,FALSE,FALSE,TRUE,FALSE,1731,1429,1251,TEST,B) continuous
616,11602,1863515,leucocyte count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-423,,0,,"given as estimated change and no std given, also in figure and graphic format",TRUE,TRUE,TRUE,FALSE,3963,3457,3103,TEST,B) continuous
133,2453,4574984,overall mortality,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,45,326,58,326,,,,,Used numbers from 1 year after surgery (final timepoint) to get the full scope since the outcome is OVERALL mortality. This info is found in Figure 6 caption.,FALSE,FALSE,FALSE,TRUE,12997,7944,5795,TEST,B) continuous
144,1272,4880652,"diastolic blood pressure at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Means in figure 4's graphics.,TRUE,FALSE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
76,3744,3546023,The percentage of B cells,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.06,3.81,14.4,4.03,Values are between baseline and week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
275,6420,3654355,Fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-15.7,5.3,-0.4,5,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
308,7832,4541185,duration of analgesia,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,878.33,89.955,613.1,51.797,found in text,FALSE,TRUE,TRUE,TRUE,1359,1043,907,TEST,B) continuous
504,6485,5419060,Phlebotomy questionnaire score: CHC B,Phlebotomy training programme,Control,continuous,,23,,23,93,1.37,58,7.12,Back calculated SD using CI,FALSE,FALSE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
596,11583,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
216,2915,5459456,new bone formation around the screws and bone-implant contact (BIC) in both sections,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating,ACVC,continuous,,8,,8,,,,,,TRUE,FALSE,FALSE,FALSE,13404,7477,5693,TEST,B) continuous
619,11603,1863515,leucocyte count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,8818,,8362,,"means given but no std given, tables and figures in graphic format",TRUE,TRUE,TRUE,FALSE,3963,3457,3103,TEST,B) continuous
387,1119,3577738,focused on the social presence elements in terms of frequency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,FALSE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
244,10306,5571493,Glycemic level,Dw 5% with Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,0.82,0.05,0.92,0.07,,FALSE,FALSE,FALSE,TRUE,1507,1019,928,TEST,B) continuous
666,13296,4987981,total cholesterol,metformin,placebo,continuous,,21,,23,206.9,36.2,184.4,37.5,Values seperated and found in table,FALSE,TRUE,FALSE,TRUE,9637,7894,5779,TEST,B) continuous
409,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,TL+SNL group,continuous,,90,,95,73.3,6.9,65.8,7.3,Available in abstract and table,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
119,2981,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Mild-cooling,No cooling,continuous,,10,,13,70,,15.4,,,FALSE,TRUE,TRUE,FALSE,3049,2670,2328,TEST,B) continuous
397,2240,4678179,progression-free-survival (PFS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,,,,,Median was only given.,FALSE,FALSE,FALSE,FALSE,9517,6474,5204,TEST,B) continuous
673,13314,4550271,treatment according to guidelines,provider,control,continuous,,14,,12,36.4,32,22.6,23,mean given as percent and std has no unit,FALSE,TRUE,FALSE,TRUE,24886,12978,8556,TEST,B) continuous
430,3261,3475525,Scores on the saturated fat quiz,MTL group,choices group,continuous,,98,,98,90.7,20.4,35.7,15.9,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
622,11904,3493722,eradication rate of H. pylori in PP,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,81,72,81,,,,,"found in abstract and table, assumed binary because given as percentage of population",FALSE,FALSE,FALSE,TRUE,1684,1549,1357,TEST,B) continuous
519,6700,5154016,Second 24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,63.3,8.9,63.5,14.2,,FALSE,TRUE,FALSE,TRUE,3046,2156,1642,TEST,B) continuous
567,8560,5541727,Tibial bone expansion,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-0.7,1.5,1,1.1,"Values are from ""total tibial plateau"" for 24 months",FALSE,TRUE,FALSE,TRUE,6118,5345,4032,TEST,B) continuous
611,11584,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
354,4497,5874317,Horizontal countermovement jump,Bilateral training,Unilateral training,continuous,,9,,9,2.34,0.07,2.21,0.15,Found in table raw values,FALSE,TRUE,FALSE,TRUE,10785,5696,4631,TEST,B) continuous
490,6383,3786549,Baseline characteristics: deliveries,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,2.14,1.76,2.64,1.79,,FALSE,TRUE,FALSE,TRUE,9725,6231,4323,TEST,B) continuous
657,13176,5773985,objective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,,,,7.4,1.93,7.28,1.59,Found in abstract and results,FALSE,FALSE,FALSE,FALSE,2609,2261,1917,TEST,B) continuous
153,13479,5055753,The percentages of patients in the sedated scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,17,40,7,40,,,,,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",FALSE,FALSE,FALSE,TRUE,3292,2470,2114,TEST,B) continuous
101,1886,4188762,heart rate,remifentanil,normal saline,continuous,,30,,30,,,,,,TRUE,FALSE,TRUE,FALSE,2068,1758,1564,TEST,B) continuous
696,5639,5712123,morphine requirements,D group,P group,continuous,,30,,30,,,,,found in fig3,TRUE,FALSE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
558,9831,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Control,continuous,,12,,16,-4,12.35,-8,65.41,From per protocol,FALSE,TRUE,FALSE,TRUE,6022,3786,2937,TEST,B) continuous
287,6100,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,,,,,"F-values given, not sure how to use them",FALSE,FALSE,FALSE,FALSE,7350,5561,4156,TEST,B) continuous
381,225,1475568,Cardiac-related hospitalization,Follow-up and thorough education on self-care,Standard information about self-care,binary,20,59,25,64,,,,,Used percentage found in text to calculate actual number for binary variable.,FALSE,FALSE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
586,11522,547916,matrix metalloproteinase-9 (MMP-9),doxycycline (100 mg),placebo,continuous,,10,,4,2.18,1.94,3.26,3.58,found in abstract,FALSE,FALSE,FALSE,TRUE,4542,3636,2822,TEST,B) continuous
79,3740,3546023,tocotrienol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,587.68,87.5,59.49,4.21,Values are between baseline and week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
436,3261,3475525,Scores on sodium quiz,MTL group,No label group,continuous,,98,,99,93.5,16.4,42.6,20.7,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
316,9843,4928400,Postoperative pain,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.3,1,3.6,1.2,,FALSE,TRUE,FALSE,TRUE,4037,2288,1670,TEST,B) continuous
638,12721,4132222,"higher prevalence of lesion scabbing, a sign of healing",application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,no raw values given and can only be estimated from figure,FALSE,FALSE,FALSE,FALSE,2177,1885,1617,TEST,B) continuous
44,6986,3169777,Plasma endothelin-1 concentrations,macitentan dose of 600 mg,placebo,continuous,,6,,14,,,,,The mean and SD are in bar chart (figure),TRUE,FALSE,FALSE,FALSE,5143,4376,3326,TEST,B) continuous
461,4430,5726464,25(OH)D levels,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
292,6104,4215531,MCCB performance : Working Memory,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,48.2,9.2,50.8,12.1,used post values and Treatment as Usual as Baseline,FALSE,TRUE,FALSE,TRUE,7351,5561,4156,TEST,B) continuous
418,3262,3475525,intent of purchase,MTL group,choices group,continuous,,98,,98,3.8,1.4,4.1,1.7,Used values for self.,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
52,5306,3195393,Restraint frecuency,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,13.6,0.07,11.5,0.13,Added intermittent and continuous numbers from study site,FALSE,TRUE,FALSE,TRUE,15527,8380,5589,TEST,B) continuous
49,6989,3169777,adverse event profile - headache,macitentan doses of 100 mg,placebo,binary,1,6,3,14,,,,,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",FALSE,TRUE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
528,6919,4411165,diastolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,Numerical values are only in the figures.,TRUE,FALSE,FALSE,FALSE,3146,2589,2336,TEST,B) continuous
334,5081,5617873,Inappropriate speech,Aripiprazole,Placbeo,continuous,,45,,47,-2.2,0.4,-1.5,0.4,"table 2, given as mean change",FALSE,TRUE,FALSE,TRUE,7551,5383,4396,TEST,B) continuous
554,9720,3648394,pNN50,10-week yoga program,Control,continuous,,18,,19,20.7,25.3,19.4,18.4,Numerical values are from Week 11.,FALSE,TRUE,FALSE,TRUE,9556,6245,4261,TEST,B) continuous
141,1272,4880652,the modified Aldrete scores at 60 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Mean and SD are in table that is in graphic form.,FALSE,TRUE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
38,6985,3169777,unexpected adverse events,macitentan doses of 1 mg,placebo,binary,0,6,0,14,,,,,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,FALSE,FALSE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
140,1275,4880652,SpO2 at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Mean in figure 5's graphics.,TRUE,FALSE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
175,10752,5086025,Intuitive eating total score,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,3.45,0.55,2.54,0.58,Actually comparing preintervention and postintervention,FALSE,TRUE,FALSE,TRUE,29049,17627,13068,TEST,B) continuous
457,4424,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,20,,20,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,TRUE,TRUE,FALSE,1396,1236,1068,TEST,B) continuous
469,4799,5515881,dynamic balance performance on the stability platform,demanding balance training program,relaxation group,continuous,,,,,7.54,2.57,6.29,1.84,Group sizes are in methods section only. Numerical values are from posttest.,TRUE,TRUE,FALSE,FALSE,4475,3500,2868,TEST,B) continuous
548,8462,3263860,Diabetic ketoacidosis,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,Unclear group sizes. Used the group size for 26-week visit.,FALSE,FALSE,TRUE,TRUE,3178,2587,2232,TEST,B) continuous
493,6484,5419060,Sample rejection rate: CDC C,Phlebotomy training programme,Control,binary,37,2279,38,2321,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
415,3262,3475525,Taste perception,MTL+caloric intake group,choices group,continuous,,90,,98,5.4,1.4,5.3,1.5,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
577,8567,2952311,Salivary alpha-amylase,Acupressure at distal points,Acupressure at local points,continuous,,11,,11,,,,,Numerical values in figure.,TRUE,FALSE,FALSE,FALSE,3603,2475,2143,TEST,B) continuous
28,3244,2972614,Motion range - Shoulder internal rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,49.33,9.62,49.77,4.49,Outcome originally just Motion range.,FALSE,TRUE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
544,7792,3508963,Pain score after 5 minutes,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,3.18,2.27,4.45,2.16,,FALSE,TRUE,FALSE,TRUE,3561,2387,1552,TEST,B) continuous
375,219,1475568,Baseline systolic dysfunction,Follow-up and thorough education on self-care,Standard information about self-care,binary,23,59,28,64,,,,,Used percentage found in table to calculate actual number for binary variable.,FALSE,TRUE,FALSE,TRUE,4361,3649,2573,TEST,B) continuous
6,11451,1574360,The amount of saturated fat in the foods purchased,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.77,1.37,0.04,0.32,Have to use CI to calculate the SDs,FALSE,FALSE,TRUE,TRUE,1959,1620,1376,TEST,B) continuous
183,4341,5122613,Baseline characteristics and diet,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,10,4.6,11.5,4.6,Mean daily fiber intake,FALSE,FALSE,FALSE,TRUE,6184,3742,2832,TEST,B) continuous
426,3403,3877023,Scanning times,high-field horizontal open MR scanner,short-bore MR scanner,continuous,,49,,44,32,22,20,9,,FALSE,FALSE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
589,11583,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
678,13505,5777419,the total cultivable microbiota,antibiotic,placebo,continuous,,16,,15,,,,,median and IQ scores given,FALSE,TRUE,FALSE,FALSE,9410,4699,3181,TEST,B) continuous
568,8555,5541727,Treatment-related serious adverse events,Allogeneic mesenchymal precursor cells,Control,binary,0,11,0,6,,,,,,FALSE,FALSE,FALSE,TRUE,6118,5345,4032,TEST,B) continuous
349,10236,5686687,CA-125 levels,Resveratrol,Placebo,continuous,,22,,22,,,,,median and ranges given,FALSE,TRUE,FALSE,FALSE,7451,3515,2366,TEST,B) continuous
126,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H1(haloperidol 1 mg),continuous,,50,,49,,,,,Data is in figure.,TRUE,FALSE,FALSE,FALSE,3932,3205,2434,TEST,B) continuous
563,9837,3496170,Self-report questionnaire,Biperiden,Placebo,continuous,,15,,15,,,,,No numerical values are given.,FALSE,FALSE,TRUE,FALSE,2318,1990,1731,TEST,B) continuous
207,5501,5380326,Tumor necrosis factor alpha,Vitamin D supplementation,Control,continuous,,40,,40,752.94,1890.16,548.33,1210.9,,FALSE,TRUE,FALSE,TRUE,10658,5810,4260,TEST,B) continuous
556,9828,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Control,continuous,,12,,16,-17.1,68.08,-19.57,93.53,From per protocol,FALSE,TRUE,FALSE,TRUE,6022,3786,2937,TEST,B) continuous
600,11583,115849,Tender joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
9,9684,2363753,Hospital stay,Amifostine,Control,continuous,,20,,20,,,,,Only abstract is available. Full text in PDF only.,FALSE,FALSE,FALSE,FALSE,887,780,725,TEST,B) continuous
636,12291,5777645,Mean waist circumference,to peer-led structured patient education,conventional care alone,continuous,,,,,-3.34,9.3,2.65,10.3,SDs found in abstract while group sizes and means found in table 2,FALSE,TRUE,FALSE,TRUE,8661,5060,3738,TEST,B) continuous
179,10756,5086025,BMI,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,32.81,5.31,32.93,4.85,,FALSE,TRUE,FALSE,TRUE,29049,17627,13068,TEST,B) continuous
489,6383,3786549,Baseline characteristics: weight,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,56.16,8.1,57.82,8.24,,FALSE,TRUE,FALSE,TRUE,9725,6231,4323,TEST,B) continuous
649,13097,5976307,total procedure time,etomidate,propofol based on midazolam,continuous,,,,,,,,,found in table 2,FALSE,TRUE,TRUE,FALSE,2560,2044,1751,TEST,B) continuous
699,5638,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),etoricoxib (E),continuous,,30,,30,,,,,found in fig2,TRUE,FALSE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
668,13296,4987981,triglycerides levels,metformin,placebo,continuous,,21,,23,194.3,63.1,181.8,61.3,Values seperated and found in table,FALSE,TRUE,FALSE,TRUE,9637,7894,5779,TEST,B) continuous
630,12235,3510731,Median time in seconds (interquartile range) - Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,3.5,,3.6,,"found in table 1, IQ range given rather and std",FALSE,TRUE,FALSE,FALSE,1665,1296,943,TEST,B) continuous
135,2450,4574984,Health-Related Quality of Life at 12 month - males,"intervention group, i.e. patient empowerment through information booklet and diary keeping - males","control group, which received standard care - males",continuous,,216,,231,72.49,23.66,71.71,27.1,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,FALSE,FALSE,FALSE,TRUE,12997,7944,5795,TEST,B) continuous
20,3246,2972614,Adverse effects,Laser therapy (Group I),Placebo laser therapy (Group II),binary,0,30,0,22,,,,,,FALSE,FALSE,FALSE,TRUE,7041,2968,1931,TEST,B) continuous
301,5600,4355974,Days patient had to slow down,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-0.4,,"standard deviations not given, means are mean change",FALSE,TRUE,FALSE,FALSE,7450,5464,3820,TEST,B) continuous
523,6741,5325897,First test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,10.24,0.77,9.73,0.77,,FALSE,FALSE,FALSE,TRUE,4260,2410,1703,TEST,B) continuous
434,3261,3475525,Scores on sugar quiz,MTL group,choices group,continuous,,98,,98,90,20.7,41.9,19.4,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
438,3261,3475525,Scores on sodium quiz,MTL group,choices group,continuous,,98,,98,93.5,16.4,47.1,21.1,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
80,3740,3546023,tocopherol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,14.56,3.06,11.75,2.27,Values are between baseline and week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
669,13296,4987981,triglycerides levels,pioglitazone,placebo,continuous,,16,,23,200.1,55.9,181.8,61.3,Values seperated and found in table,FALSE,TRUE,FALSE,TRUE,9637,7894,5779,TEST,B) continuous
670,13297,4987981,IL-6 and TNF-α levels,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,Values combined and given in figure,TRUE,FALSE,FALSE,FALSE,9637,7894,5779,TEST,B) continuous
174,2796,5079604,The probability of relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,9,33,11,15,,,,,Used percentage to calculate events as binary outcome.,FALSE,FALSE,FALSE,TRUE,12690,6902,4923,TEST,B) continuous
130,4925,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H2 (haloperidol 2 mg),binary,11,49,10,50,,,,,Used numbers from Late time (2–24 h),FALSE,TRUE,FALSE,TRUE,3932,3205,2434,TEST,B) continuous
63,1642,3309311,differences in the annulus tear,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,23,23,5,19,,,,,Used percentage to calculate events as binary outcome.,FALSE,TRUE,TRUE,TRUE,1437,1263,1073,TEST,B) continuous
110,9521,4319071,High-energy snack intake,Individual cognition and self-regulation processes intervention,Control,continuous,,459,,434,2.5,2.79,2.84,2.71,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,FALSE,TRUE,FALSE,TRUE,26475,16822,9628,TEST,B) continuous
549,8464,3263860,PAID questionnaire fear of hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,,,,,Numerical values in Table which is a graphic,FALSE,TRUE,TRUE,FALSE,3178,2587,2232,TEST,B) continuous
565,9839,3496170,N1 amplitude,Biperiden,Placebo,continuous,,15,,15,,,,,numerical data in figure.,TRUE,FALSE,TRUE,FALSE,2318,1990,1731,TEST,B) continuous
159,7710,5056957,BMI reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,21.07,6.39,21.27,5.9,Back calculated the SD values from CI,FALSE,TRUE,FALSE,TRUE,11185,6045,4394,TEST,B) continuous
620,11603,1863515,absolute neutrophil count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,5639,,6150,,"means given but no std given, tables and figures in graphic format",TRUE,TRUE,TRUE,FALSE,3963,3457,3103,TEST,B) continuous
689,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),no further reminder (IG1),binary,94,102,84,104,,,,,found in text as fractions of group sizes,FALSE,FALSE,FALSE,TRUE,10493,8112,5695,TEST,B) continuous
452,4001,4879328,weight loss,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.33,0.3,3.54,Back calculated SD using CI.,FALSE,TRUE,FALSE,TRUE,12872,8442,5640,TEST,B) continuous
482,5524,4144850,E. coli contaminated water,Total Sanitation Campaign,Control,binary,310,404,331,403,,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
313,9840,4928400,Stone-free rate,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,22,22,16,20,,,,,,FALSE,TRUE,FALSE,TRUE,4037,2288,1670,TEST,B) continuous
595,11583,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
296,5595,4355974,Days of wheeze,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-4.2,,standard deviations not given and means are mean change,FALSE,TRUE,FALSE,FALSE,7450,5464,3820,TEST,B) continuous
693,5636,5712123,postoperative pain at rest,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,2,,3,,values given as score (range),FALSE,TRUE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
315,9842,4928400,Complication,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,5,22,7,20,,,,,,FALSE,TRUE,FALSE,TRUE,4037,2288,1670,TEST,B) continuous
164,617,5062234,The visual analog scale scores at rest and on coughing,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,,,,,Data found in table in graphic format.,FALSE,TRUE,TRUE,FALSE,1345,1148,971,TEST,B) continuous
513,6549,4033571,Overall seizure median percent reduction,Extended-release oxcarbazepine 1200 mg,Control,continuous,,109,,117,-38.3,,-28.7,,SD was not given,FALSE,FALSE,FALSE,FALSE,8206,5593,4514,TEST,B) continuous
449,4004,4879328,FFBQ Total Index Score,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.07,0.26,0.01,0.33,Back calculated SD using CI.,FALSE,TRUE,FALSE,TRUE,12872,8442,5640,TEST,B) continuous
555,9721,3648394,Flexibility,10-week yoga program,Control,continuous,,18,,19,31,8.7,26.4,10.4,Numerical values are from Week 11 data for sit and reach test.,FALSE,TRUE,FALSE,TRUE,9556,6245,4261,TEST,B) continuous
257,10571,5711682,target lesion revascularization (TLR),Genoss drug-eluting stent (DES),Promus Element,binary,1,38,1,39,,,,,,FALSE,TRUE,FALSE,TRUE,13148,4660,2966,TEST,B) continuous
366,12887,5976949,leptin/adiponectin ratio (LAR),"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,0.97,1.31,0.72,0.46,found in table,FALSE,TRUE,FALSE,TRUE,4402,2905,2274,TEST,B) continuous
256,10573,5711682,myocardial infarction (MI),Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,FALSE,TRUE,FALSE,TRUE,13148,4660,2966,TEST,B) continuous
82,3745,3546023,CD4+/CD8+ ratio,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,1.19,0.43,1.03,0.53,Values are for week 24 (final timepoint).,FALSE,TRUE,FALSE,TRUE,29733,18035,11524,TEST,B) continuous
318,9845,4928400,Time for return to daily activities,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,13.3,1.7,9,1.6,,FALSE,TRUE,FALSE,TRUE,4037,2288,1670,TEST,B) continuous
454,4432,5726464,insulin,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,Median was reported.,FALSE,TRUE,FALSE,FALSE,6563,4244,3133,TEST,B) continuous
367,224,1475568,Minnesota living with heart failure (MLHF) questionnaire baseline scores,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,Only the mean score was given in table.,FALSE,TRUE,FALSE,FALSE,4361,3649,2573,TEST,B) continuous
687,13762,2836833,weight loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,TRUE,FALSE,FALSE,12992,7163,5694,TEST,B) continuous
278,6422,3654355,Baseline body mass index,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,42.8,4.6,42.8,6.3,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
72,3042,3321528,the total MRC score of the legs,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,Only median and interquartile range is given.,FALSE,FALSE,FALSE,FALSE,6725,3999,2880,TEST,B) continuous
376,223,1475568,Baseline angiotensin II receptor blockers (ARBs) intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,Unclear since the values for this are reported with ACEI intake.,FALSE,TRUE,FALSE,FALSE,4361,3649,2573,TEST,B) continuous
268,2991,3214395,laryngoscopy duration,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 45",group 3 involved bispectral index (BIS) of 35,continuous,,60,,30,,,,,mean and std not given for group 1 and 2 combined,FALSE,TRUE,TRUE,FALSE,1201,996,880,TEST,B) continuous
614,11584,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
320,4724,5539943,"sustain talk"" (ST)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,No group sizes and individual means and stds given,FALSE,FALSE,FALSE,FALSE,9850,5076,3578,TEST,B) continuous
432,3261,3475525,Scores on sugar quiz,MTL group,No label group,continuous,,98,,99,90,20.7,47.2,19.6,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
517,6695,5154016,24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,32,187.9,82,230.8,75,,FALSE,TRUE,FALSE,TRUE,3046,2156,1642,TEST,B) continuous
185,4338,5122613,Colonic transit time,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,39.7,22.3,48,25,,FALSE,TRUE,FALSE,TRUE,6184,3742,2832,TEST,B) continuous
695,5639,5712123,morphine requirements,E group,P group,continuous,,30,,30,,,,,found in fig3,TRUE,FALSE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
590,11583,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
200,7737,5380284,Consumption of fentanyl,Gum-chewing group,No gum group,continuous,,38,,37,,,,,,FALSE,TRUE,TRUE,FALSE,1731,1429,1251,TEST,B) continuous
90,5540,3912320,"Correct response rate for 4,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,Mean were in a figure and SD was not given anywhere.,TRUE,FALSE,FALSE,FALSE,1648,1217,1015,TEST,B) continuous
317,9844,4928400,Hospital stay,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.2,1.2,2.1,1.1,,FALSE,TRUE,FALSE,TRUE,4037,2288,1670,TEST,B) continuous
254,12428,5614421,side effects,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,134,394,118,382,,,,,,FALSE,TRUE,FALSE,TRUE,25930,11480,8549,TEST,B) continuous
407,2806,5781260,Interleukin 6,lemon verbena extract,placebo,continuous,,20,,20,,,,,Numerical values are not given.,FALSE,FALSE,FALSE,FALSE,4385,3505,2662,TEST,B) continuous
423,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,22.3,13.2,14,5.6,,FALSE,TRUE,FALSE,TRUE,17694,9686,7100,TEST,B) continuous
184,4337,5122613,Improvement in faeces consistency,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,3.4,1,3.2,0.5,,FALSE,TRUE,FALSE,TRUE,6184,3742,2832,TEST,B) continuous
417,3262,3475525,intent of purchase,MTL+caloric intake group,No label group,continuous,,90,,99,3.6,1.4,4.1,1.5,Used values for self.,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
508,6486,5419060,Techinque related rejections: CHC B,Phlebotomy training programme,Control,binary,15,4114,8,3973,,,,,,FALSE,TRUE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
667,13296,4987981,total cholesterol,pioglitazone,placebo,continuous,,16,,23,207.2,42.3,184.4,37.5,Values seperated and found in table,FALSE,TRUE,FALSE,TRUE,9637,7894,5779,TEST,B) continuous
661,13216,4458006,amplitude of whisking,facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1),"2 cm distally, at the main bifurcation (group 2)",continuous,,12,,12,17.2,,6.9,,No std given,FALSE,FALSE,FALSE,FALSE,1302,1180,1009,TEST,B) continuous
121,7938,4486927,"The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype",peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,17,23,2,24,,,,,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",FALSE,TRUE,FALSE,TRUE,14472,7883,5770,TEST,B) continuous
683,13506,5777419,reduction of PPD,antibiotic,placebo,continuous,,16,,15,2.3,0.3,2.5,0.6,found in table 2,FALSE,TRUE,FALSE,TRUE,9410,4699,3181,TEST,B) continuous
98,931,4183415,completion of each dose at the correct time,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,33.1,21.6,32.6,18.4,Data found in Table 6.,FALSE,TRUE,FALSE,TRUE,10420,7106,5310,TEST,B) continuous
340,11079,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
277,6422,3654355,Baseline Height,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,173.2,8.6,172.3,10.4,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
61,1642,3309311,differences in the disc herniation,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,20,23,6,19,,,,,Used percentage to calculate events as binary outcome.,FALSE,TRUE,TRUE,TRUE,1437,1263,1073,TEST,B) continuous
87,13569,3687098,The incidence of the composite endpoint of rash,sitagliptin 100 mg/day,comparator agent,binary,131,7726,76,6885,,,,,Used incidence rate per 100 to get the binary events.,FALSE,TRUE,FALSE,TRUE,15196,10904,8432,TEST,B) continuous
221,2914,5459456,Flexion-Extension stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.34,0.12,7.47,1.45,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",FALSE,TRUE,FALSE,TRUE,13404,7477,5693,TEST,B) continuous
635,12290,5777645,Mean BMI change,to peer-led structured patient education,conventional care alone,continuous,,,,,-1.65,2.5,0.05,3.2,SDs found in abstract while group sizes and means found in table 2,FALSE,TRUE,FALSE,TRUE,8661,5060,3738,TEST,B) continuous
414,3262,3475525,Taste perception,MTL group,choices group,continuous,,98,,98,5.6,1.4,5.3,1.5,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
344,11082,5655920,Hypoglycaemia,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,TRUE,FALSE,FALSE,13081,5825,4026,TEST,B) continuous
609,11584,115849,Tender joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
97,10168,4173437,Crystalloid solution needed,Tranexamic acid,Control,continuous,,30,,30,,,,,Had to infer that the group sizes were equal. No numerical values associated with this outcome.,FALSE,FALSE,TRUE,FALSE,854,745,637,TEST,B) continuous
431,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.3,15.1,35.7,15.9,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
145,1272,4880652,heart rates,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,Means in figure 2's graphics.,TRUE,FALSE,TRUE,FALSE,1406,1149,966,TEST,B) continuous
593,11583,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
514,6551,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 1200 mg,Control,continuous,,,,,-34.5,,-13.3,,"Group sizes are only in figure, and SD is not available.",TRUE,FALSE,FALSE,FALSE,8206,5593,4514,TEST,B) continuous
53,5307,3195393,Intermittent restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,5.1,0.07,0.7,0.02,Overall intermittent restraint rate for study site.,FALSE,TRUE,FALSE,TRUE,15527,8380,5589,TEST,B) continuous
314,9841,4928400,Operative time,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,74.1,12.2,78,6.4,found in table,FALSE,TRUE,FALSE,TRUE,4037,2288,1670,TEST,B) continuous
396,1120,3577738,interest,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,FALSE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
411,3260,3475525,Correct selection of the healthier product,choices group,TL+SNL group,continuous,,98,,95,72.5,13.2,65.8,7.3,Available in abstract and table,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
116,2982,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,Mild-cooling,continuous,,9,,10,,,70,,,FALSE,TRUE,TRUE,FALSE,3049,2670,2328,TEST,B) continuous
433,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.6,15.5,47.2,19.6,,FALSE,TRUE,FALSE,TRUE,9086,4934,3542,TEST,B) continuous
111,9522,4319071,High-energy snack intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.5,2.76,2.84,2.71,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,FALSE,TRUE,FALSE,TRUE,26475,16822,9628,TEST,B) continuous
692,5635,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Duloxetine (D),continuous,,30,,30,,,,,found in fig2,TRUE,FALSE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
388,1119,3577738,focused on the social presence elements in terms of duration,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,FALSE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
264,2786,2430617,HBeAg sero-conversion rate,60 µg of immune complexes (YIC),placebo,binary,17,78,7,78,,,,,effects found in abstract and exact number in results table,FALSE,TRUE,FALSE,TRUE,7987,4896,3773,TEST,B) continuous
177,10754,5086025,General mental health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.24,7.41,45.63,6.31,,FALSE,TRUE,FALSE,TRUE,29049,17627,13068,TEST,B) continuous
672,13313,4550271,Community knowledge,provider-school intervention,control,continuous,,14,,12,,,,,outcome too broad,FALSE,TRUE,FALSE,FALSE,24886,12978,8556,TEST,B) continuous
392,1120,3577738,efficiency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,FALSE,FALSE,FALSE,3018,2080,1653,TEST,B) continuous
688,13763,2836833,systolic or diastolic blood pressure,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,TRUE,FALSE,FALSE,12992,7163,5694,TEST,B) continuous
181,4339,5122613,Left SCTT,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,10.2,8.6,12.1,9.5,Had to do some simple math to get accurate group size.,FALSE,TRUE,FALSE,TRUE,6184,3742,2832,TEST,B) continuous
12,12632,2667135,number of days with received courses of antibiotics,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,continuous,,103,,97,25.4,23.34,13.5,9.49,,FALSE,FALSE,FALSE,TRUE,11722,8106,5529,TEST,B) continuous
328,5375,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 64 mg,continuous,,5,,4,,,,,found in table,FALSE,TRUE,TRUE,FALSE,1146,884,721,TEST,B) continuous
647,13025,4675066,The mean motor score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,93.9,10.8,92.4,9.7,found in table 2,FALSE,TRUE,FALSE,TRUE,6682,5735,4224,TEST,B) continuous
503,6485,5419060,Phlebotomy questionnaire score: CHC A,Phlebotomy training programme,Control,continuous,,23,,23,96,3.89,63,12.31,Back calculated SD using CI,FALSE,FALSE,FALSE,TRUE,9292,5719,4155,TEST,B) continuous
269,2991,3214395,laryngospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 46",group 3 involved bispectral index (BIS) of 36,binary,,60,,30,,,,,,FALSE,TRUE,TRUE,FALSE,1201,996,880,TEST,B) continuous
473,5711,3343759,aphasia types,very early speech and language therapy (SLT),control,binary,,,,,,,,,Numerical data is in figure and group sizes are not available in abstract or results sections.,TRUE,FALSE,FALSE,FALSE,3838,2633,2065,TEST,B) continuous
691,13831,4210722,use of a reminder card,a separate reminder card 4 days before the appointment (IG3); reminder card together with the appointment letter (IG2);,no further reminder (IG1),binary,185,209,84,104,,,,,found in text as fractions of group sizes,FALSE,FALSE,FALSE,TRUE,10493,8112,5695,TEST,B) continuous
243,8057,5534041,composite z-scores in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.13,0.82,-0.25,0.71,,FALSE,TRUE,FALSE,TRUE,6951,5679,4357,TEST,B) continuous
618,11603,1863515,haemoglobin level at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,10.7,,11.2,,"means given but no std given, tables and figures in graphic format",TRUE,TRUE,TRUE,FALSE,3963,3457,3103,TEST,B) continuous
36,6988,3169777,adverse event profile - headache,macitentan dose of 600 mg,placebo,binary,5,6,3,14,,,,,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",FALSE,TRUE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
660,13179,5773985,number of analgesic tablets,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,,,,,,,,Graphic format table,FALSE,TRUE,TRUE,FALSE,2609,2261,1917,TEST,B) continuous
561,9835,3496170,P3a amplitude,Biperiden,Placebo,continuous,,15,,15,,,,,numerical data in figure.,TRUE,FALSE,TRUE,FALSE,2318,1990,1731,TEST,B) continuous
282,6422,3654355,baseline skeletal muscle mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,38.4,7.9,37.9,7.4,,FALSE,TRUE,FALSE,TRUE,18948,9604,6664,TEST,B) continuous
267,12440,2596788,GERD-knowledge,education,control,continuous,,102,,109,17.1,,14,,no standard deviations given,TRUE,FALSE,FALSE,FALSE,5143,3554,2520,TEST,B) continuous
112,9525,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,167.61,83.71,158.67,78.33,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,FALSE,TRUE,FALSE,TRUE,26475,16822,9628,TEST,B) continuous
39,6985,3169777,unexpected adverse events,macitentan doses of 5 mg,placebo,binary,0,6,0,14,,,,,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,FALSE,FALSE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
41,6985,3169777,unexpected adverse events,macitentan doses of 100 mg,placebo,binary,0,6,0,14,,,,,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,FALSE,FALSE,FALSE,TRUE,5143,4376,3326,TEST,B) continuous
476,5523,4144850,Open defecation - adult women,Total Sanitation Campaign,Control,binary,1116,"1,525",1264,"1,514",,,,,Used percent to calculate outcomes for binary variables.,FALSE,TRUE,FALSE,TRUE,24614,13328,9179,TEST,B) continuous
648,13097,5976307,induction time,etomidate,propofol based on midazolam,continuous,,,,,,,,,found in table 2,FALSE,TRUE,TRUE,FALSE,2560,2044,1751,TEST,B) continuous
106,1885,4188762,mean blood pressure,remifentanil,"normal saline, lidocaine, or ketamine",continuous,,30,,30,,,,,,TRUE,FALSE,TRUE,FALSE,2068,1758,1564,TEST,B) continuous
602,11583,115849,Patient global assessment of pain,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,TRUE,FALSE,FALSE,6464,5362,4091,TEST,B) continuous
122,7936,4486927,The early virologic response (EVR),peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,86,94,82,93,,,,,,FALSE,TRUE,FALSE,TRUE,14472,7883,5770,TEST,B) continuous
160,7711,5056957,BMI z-score at 12months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,0.61,1.8,0.66,1.69,Back calculated the SD values from CI,FALSE,TRUE,FALSE,TRUE,11185,6045,4394,TEST,B) continuous
272,2991,3214395,extremity movement,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 49",group 3 involved bispectral index (BIS) of 39,binary,,60,,30,,,,,,FALSE,TRUE,TRUE,FALSE,1201,996,880,TEST,B) continuous
294,6104,4215531,MCCB performance : Reasoning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.9,8.8,46.5,9.8,used post values and Treatment as Usual as Baseline,FALSE,TRUE,FALSE,TRUE,7353,5561,4156,TEST,B) continuous
325,5372,5559992,Anxiety,Buprenophine 32 mg,No treatment,continuous,,5,,5,,,,,"decided ""no treatment"" meant baseline",FALSE,TRUE,TRUE,FALSE,1146,884,721,TEST,B) continuous
34,5578,3003523,Mental Component Summary improvement,Certolizumab 400 mg,Control,continuous,,390,,199,45.4,11.5,41.1,10.8,Used values for MCS after 52 weeks (final timepoint).,FALSE,TRUE,FALSE,TRUE,12247,10091,7520,TEST,B) continuous
132,2452,4574984,level of postoperative pain,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,234,326,261,326,,,,,,FALSE,TRUE,FALSE,TRUE,12997,7944,5795,TEST,B) continuous
698,5637,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Placebo group (P),continuous,,30,,30,,,,,found in fig2,TRUE,FALSE,FALSE,FALSE,6401,5359,3891,TEST,B) continuous
